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ABSTRACT 
Daniel Carl Anacker: Manipulation of the Host Cell DNA Damage Pathways by 
Human Papillomavirus 
(Under the direction of Cary Moody) 
 
 
Human papilloma virus (HPV) is thought to be the most common sexually 
transmitted viral infection in the United States. It poses a major public health risk 
since persistent infection with certain types of HPV is a major risk factor for several 
cancers. HPV is highly adapted for immune evasion and follows a strictly regimented 
life cycle in order to evade immune detection. The HPV life cycle is closely tied to 
host cell differentiation with late viral events, such as structural gene expression and 
viral genome amplification taking place in the differentiating upper layers of the 
epithelia, removed from immune detection.  The virus accomplishes this through a 
complex system of host cell manipulation, and tight control of its own gene 
expression and genome replication 
This dissertation addresses how the virus, with its very limited coding 
capacity, has managed to commandeer the many host factors required to 
successfully replicate the viral genome. I specifically investigated how the virus, 
especially the viral oncogenes E6 and E7 interface with the ATM and ATR 
dependent DNA damage response (DDR), in order to create an atmosphere 
conducive to productive viral replication in a differentiating keratinocyte. First, we 
expanded on previous work that indicated the ATM DDR response was constitutively 
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activated in HPV positive cells and necessary for successful productive viral genome 
replication. We determined that Nbs1, a protein involved in the ATM DDR pathway, 
known to be recruited to sites of HPV replication, was required for productive viral 
genome replication. However, we found that Nbs1 plays a role in viral genome 
amplification outside of its ability to activate ATM. Our evidence suggests that Nbs1 
may recruit other proteins, involved in homologous repair (HR), that may be needed 
for productive viral replication. We next investigated how the virus may be activating 
the ATR DDR in order to provide other factors necessary for viral genome synthesis. 
Previous research has shown that the ATR DDR is activated in HPV positive cells 
and that levels of the ribonucleotide reductase (RNR) small subunit M2 (RRM2) are 
upregulated. In this dissertation we show that levels of deoxyribonucleotide 
triphosphates (dNTPs) are elevated in HPV positive cells, both prior to and post 
differentiation. We have found that RRM2 levels in these cells are upregulated in an 
ATR/Chk1/E2F1 dependent manner and that RRM2 is necessary for viral genome 
replication, especially upon differentiation. 
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CHAPTER 1: INTRODUCTION 
OVERVIEW 
Human Papilloma Virus (HPV) is a double stranded non-enveloped DNA virus 
that infects epithelial cells known as keratinocytes. Specifically, alpha-HPVs target 
the mucosal epithelia of the anogenital tract and oropharynx. The range of HPVs can 
be further broken down into viral subtype with viral genome sequence and antibody 
recognition differing significantly between viral subtypes. Broadly they can be divided 
into two groups, high and low risk, based on their association with cancer. While low 
risk subtypes such as HPV 6 and 11 typically cause benign warts, the high risk 
subtypes, including HPV 16, 18, 31, and 45 are known to cause cervical, penile, 
anal, and head and neck cancers. Cervical cancer alone is the second leading 
cause of cancer deaths among women with 490,000 cases and 270,000 deaths 
worldwide each year (1). HPV is thought to be the most common sexually 
transmitted viral infection, with an overall prevalence of 26% in US females aged 14 
to 59 and a peak prevalence of over 44% in women ages 20-24 (2). Since among 
HPV subtypes, high risk HPVs pose the largest known threat to public health, my 
dissertation research specifically focused on these viruses.  
INTRODUCTION 
The HPV genome exists as a circular episome of 7.5 to 8kb in length 
depending on the specific viral subtype. The genome typically encodes eight 
proteins; early proteins E1, E2, E4, E5, E6, and E7 and the late proteins L1 and L2. 
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The early proteins are non-structural and are involved in a variety of functions 
ranging from viral genome replication to cell cycle control. E1 is the virally encoded 
helicase that also recruits host DNA replication factors to the viral origin of 
replication (3). E2 is the viral transcription factor that also cooperates with E1 to 
facilitate the initiation of viral genome amplification (4-7). E6 and E7 are viral 
oncoproteins that perform a wide variety of functions ranging from anti-apoptotic 
functions to cell cycle manipulations (7-9). L1 and L2 are the two structural proteins 
that form the viral capsid. The functions of proteins E4 and E5 have not been 
completely described. E4 is also commonly referred to as E1^E4 as it is expressed 
from a spliced mRNA consisting of the first 5 amino acids of the E1 ORF followed by 
the entire E4 ORF (10). E5 is thought to interact with cellular EGFR receptors and 
play an undetermined role in viral genome amplification (11). The HPV life cycle, 
which is tightly tied to host cell differentiation can be described in 3 main stages; 
establishment, maintenance, and amplification, each of which involves viral genome 
replication. However, since the HPV genome does not encode any polymerases or 
many other proteins necessary for viral genome replication, the virus must rely on 
host DNA synthesis machinery in order to replicate the viral genome.  
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Figure 1.1 HPV viral genome organization. Open reading frames are indicated 
with arrows and the long control region (LCR) is indicated by a black square. The 
early and late promoters are also indicated (PE and PL respectively). 
 
THE DIFFERENTIATION DEPENDENT VIRAL LIFE CYCLE 
Initial infection: As previously mentioned HPVs, are known to target 
mucosal epithelia, specifically the mucosal epithelia of the anogenital tract and 
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oropharynx (12). While this specific tropism has been well described, the actual 
process of viral attachment and entry are not completely understood. Infection is 
known to require small epithelial abrasions known as microwounds (8). These micro 
wounds are tiny tears in the epithelia that allow virions to access the basement 
membrane. Once bound to the basement membrane the virion is able to come into 
contact with the basal layer of keratinocytes. Once in contact with the basal 
keratinocyte, L1 capsid protein on the virion surface is thought to attach to heparin 
sulfate proteoglycans (HSPGs) on the cell surface (13). After the initial attachment 
event there is a conformational change in the capsid structure and the L2 protein is 
cleaved by host cell furin (14). At this point it is currently thought that the virion binds 
an unknown secondary cellular receptor which mediates viral entry into the cell. The 
mechanism by which the virus enters the cell is still unclear. A variety of entry 
pathways have been reported, leading to the suggestion that the viral entry 
mechanism may be viral subtype dependent (15).  
Establishment Phase: Upon Host cell entry the virus un-coats and unloads 
its genome into endosomes (12).  Viral genomes are then released from the 
endosomes into the cytoplasm, this process has been shown to be dependent on 
the same L2 furin cleavage event that has been shown to play a role in viral 
attachment (16).  After the viral genomes have entered the cytoplasm, L2 is also 
involved in transferring the cytoplasmic genomes to the host cell nucleus (5). Once 
in the host nucleus, in order for persistent infection to be established early proteins 
must be expressed. These proteins include the viral replication proteins E1 and E2, 
along with the oncoproteins E6 and E7. Expression of the transcripts for these 
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proteins is mediated by the early promoter which is located directly upstream of the 
E6 coding region (17). The activity of the early promoter is controlled through the 
binding of positive and negative factors to the upstream long control region (LCR) 
(18-20). At this point the viral protein E2 is very important as it is the major viral 
transcription regulator, and regulation of viral transcription is thought to be at least 
partially responsible for controlling viral copy number in undifferentiated cells (21).  
Viral genome replication also requires E1 protein, the viral helicase (22). Acting 
together in complex, E1 and E2 are able to bind the viral origin of replication with 
high affinity (22, 23). However once the complex is bound to the viral origin of 
replication, which is adjacent to the early promoter, E2 is released from the complex 
before DNA replication begins (22). E1 is then responsible for recruiting the cellular 
factors required for viral genome replication and unwinding the viral DNA (23).  
Maintenance phase: Once stable infection has been established the virus 
enters what is referred to as a maintenance phase infection. During this phase, viral 
genomes are stably maintained at a level of 50 to 100 copies per cell and the early 
proteins E1, E2, E6, and E7 continue to be expressed from the early promoter (24).  
Recent evidence suggests that during the maintenance phase the viral genome is 
replicated along with the host cell genome and is distributed equally to daughter 
cells upon cell division (22). E2 has been identified as a necessary factor to ensure 
equal separation of HPV genomes to daughter cells by tethering viral genomes to 
host chromosomes (25). The viral oncoproteins E6 and E7 are also necessary for 
the stable maintenance of viral genomes as episomes during the maintenance stage 
of infection (26). During maintenance phase, E6 is also active in binding and 
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degrading p53 (8). This activity prevents host cell apoptosis and inhibits cell cycle 
checkpoints. E7 expression during the maintenance phase is important because of 
its ability to promote destruction of retinoblastoma protein (Rb). The degradation of 
Rb deregulates the cell cycle and helps to push the cell towards a proliferative state 
by releasing E2F transcription factors which activate transcription of S phase genes 
important for DNA replication (8). 
Productive phase: The virus remains in the maintenance phase while the 
host cell remains among the basal layer of keratinocytes. When an infected basal 
cell divides, one of the daughter cells remains in the actively dividing basal layer 
while the other begins to move upward, away from the basal layer and begins to 
differentiate. This activation of host cell differentiation activates the productive phase 
of the viral life cycle (8). 
While a great deal about the link between host cell differentiation and 
triggering of the productive phase of HPV infection remains to be explained, some 
differentiation related triggers have been discovered. The viral protein E2 is 
important in controlling viral gene expression; the LCR region upstream of the early 
promoter contains multiple E2 binding sites (20, 27, 28). While a small amount of E2 
binding has been shown to activate transcription from the early promoter, large 
amounts of E2 binding have been shown to down regulate the use of this promoter 
(29). Upon differentiation the cellular transcription factors C/EBP1 and C/EBP are 
more strongly expressed (30). These transcription factors have been shown to act 
synergistically with E2 enhancing their activity. Another way in which differentiation 
triggers the activation of late viral gene expression is by modulating factors that 
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affect the late viral promoter, located downstream of the early promoter within the E7 
coding region (17, 31). It has been suggested that upon differentiation the binding 
affinity of transcriptional repressors YY1 and Cux1 for the late promoter is decreased 
possibly allowing greater transcription (11). Finally, there is evidence that upon 
differentiation, a change in the balance of expression between transcription factor 
SP1 and its antagonist SP3 and the increase in transcription factor C/EBP activate 
the late promoter (11, 32, 33).  
Aside from E2, other non-structural proteins have roles to play upon 
differentiation and induction of late viral events. E6 and E7 have been shown by 
Moody and Laimins to trigger caspase activation upon differentiation resulting in the 
cleavage of E1 (34). In the absence of this cleavage, a defect in viral genome 
replication was observed, suggesting caspase mediated cleavage activity was 
necessary for successful viral amplification (34). Upon differentiation E7 continues to 
bind and degrade Rb family proteins, releasing E2F transcription factors. This 
release of E2F factors pushes the differentiating cell back into the cell cycle and 
again triggers important S-phase genes necessary for DNA synthesis (19).  
DNA DAMAGE REPAIR 
Reliable maintenance of a stable and accurate genome is an essential 
function of every cell. In order to ensure faithful replication and maintenance of 
genomes several mechanisms exist to detect and repair damage to DNA. 
Depending on the type of damage that occurs, the cell has a variety of repair 
pathways at its disposal. As a group these pathways are known as the DNA damage 
response (DDR). Two major regulators of the DDR are the Ataxia telangiectasia 
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mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) kinases which, 
along with the DNA-dependent protein kinase (DNA-PK) are members of the PI 3-
Kinase related kinase family of kinases (35). Double strand DNA breaks (DSBs) can 
be repaired by either the high fidelity, homologous repair (HR) response regulated 
by ATM or the more error prone non-homologous end joining (NHEJ) response (35). 
Conversely damage resulting from replication stress and stalled DNA replication 
forks is handled by a pathway regulated through ATR (36, 37). HPV infection 
exploits both the ATM and ATR DDR pathways in order to successfully replicate its 
genome (38). It is thought that through these pathways, HPV maintains and recruits 
host cell factors necessary for viral genome replication, especially upon 
differentiation. It is therefore important to describe these two major DDR pathways 
and how they are exploited by HPV infection. 
ATM DNA damage repair pathway: The ATM DDR pathway is typically 
activated in response to DNA DSBs and primarily repairs DNA through HR. In this 
case, the DNA DSB is typically detected by the MRN complex which is composed of 
Mre11, Rad50, and Nbs1 (35). Rad50 is a member of the structural maintenance of 
chromosomes (SMC) family of proteins and interacts with the broken ends of DNA in 
the DSB (35). Mre11 facilitates MRN complex formation through binding both Rad50 
and Nbs1. It also has endonuclease and exonuclease activities important for 
preparing broken DNA ends for HR (39, 40). Nbs1, besides interacting with Mre11 
also directly binds ATM (41, 42). Upon recognition of the DSB the MRN recruits ATM 
to the site of damage where it binds to Nbs1 and is activated via auto 
phosphorylation (43-45). However, ATM can be activated outside of this classical 
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pathway. The competing ATM interacting (ATMIN) protein has been shown to 
activate ATM in a MRN in a Nbs1 independent manner in response to hypotonic 
stress and inhibition of DNA synthesis by drugs like Hydroxyurea (HU) (46). 
Additionally, the DNA repair protein 53BP1 has been shown to be an activator of 
ATM, especially when levels of MRN are low (47, 48). Activated ATM then 
coordinates repair of the DSB, phosphorylating a plethora of downstream targets 
including proteins involved in HR such as Nbs1, Brca1, and CtIP (49). Aside from 
recruiting ATM to the site of the DSB, the MRN complex stabilizes the break while 
MRN complex protein Mre11, along with ATM targets CtIP and Brca1 mediate 
resection of the broken ends to allow for recruitment of Rad51 mediated by Brca2 
(50) reviewed in (35). The newly recruited Rad51 replaces phosphorylated RPA 
protein on the resected strands of broken DNA leading to strand invasion of the 
homologous template, formation of the D-loop, and ultimate repair through HR (51). 
Portions of this process are also dependent on ATR and its downstream effector 
Chk1. ATR, along with ATM, have been shown to phosphorylate RPA (48). 
Additionally, Chk1 has been shown to phosphorylate Rad51 (52). Both of these 
events are important for the formation of Rad51 filaments on the resected DNA ends 
and eventual stand invasion and repair of the DSB via HR (53).  
Other important targets of ATM involved in DSB repair include histone H2AX, 
Chk2, and p53 (54-56). Phosphorylated or H2AX is an important marker of sites of 
DNA damage. H2AX foci radiate outward from the site of the DSB and serve as a 
docking site for many other DNA damage repair proteins (57). These H2AX foci can 
extend for up to two megabases beyond the site of damage and assist in the 
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recruitment of many repair factors including 53BP1, Nbs1, Brca1 and Rad51 (35) (3, 
58, 59). This allows for the amplification of the repair response through the 
recruitment of additional factors to the area of damage. Phosphorylation of Chk2 
results in arrest in G2 phase through inactivation of CDC25 and its downstream 
effector CDK1 (60). This cell cycle arrest allows time for DNA repair before 
continuation of the cell cycle. Activation of p53 also leads to cell cycle arrest and in 
the case of unrepaired damage, cell death through apoptosis (56).  
 
Figure 1.2 The ATM dependent DNA damage signaling. A DNA double strand 
break (indicated by the lightning bolt) is detected by the MRN complex which then 
recruits ATM. ATM then phosphorylates several downstream effectors. 
 
ATR DNA damage pathway: While ATR and its downstream effectors Chk1 
and Chk2 have been shown to be active in the ATM DDR pathway as outlined 
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above, ATR is also known to be the central coordinator of DDR relating to replication 
stress and replication fork stalling (36, 37). In the case of replication stress large 
regions of ssDNA coated with RPA are formed due to the decoupling of the helicase 
and polymerase (35, 61). Polymerization of RPA1 on this ssDNA recruits ATR and 
its partner protein ATRIP through a direct interaction between RPA1 and ATRIP 
(61). In this way ATR is localized to the replication fork. At the same time the RPA-
ssDNA complex also recruits the RAD17-RFC2-5 clamp loader, which in turn loads 
the 9-1-1 complex (RAD9-HUS1-RAD1) bound to the ATR activating TOPBP1 (36, 
62-65) (reviewed in (35)). This cascade of events leads to the activation of ATR at 
the stressed replication fork. Activated ATR is then able to signal through its 
downstream effectors Chk1 and Chk2. As discussed above Chk2 activation results 
in cell cycle delay. Activation of Chk1 by replication stress has recently been shown 
to result in high-level expression of genes related to DNA repair and nucleotide 
synthesis including the ribonucleotide reductase (RNR) small subunit M2 (RRM2) 
(66). Other studies have shown that ATR/Chk1 activation promotes RRM2 
accumulation by stabilizing E2F1 which transcriptionally activates RRM2 expression. 
This ATR/Chk1/E2F1 mediated increase in RRM2 is essential for providing dNTPs 
to prevent DNA damage and cell death (66-68). 
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Figure 1.3 The ATR DNA damage response. ATR is recruited to sites of replication 
stress and stalled replication forks. ATR signaling through Chk1 can result in 
increased RRM2 expression and nucleotide production to allow for DNA repair.  
  The ribonucleotide reductase enzyme: In proliferating cells, two RRM2 
subunits together with two of the larger RRM1 subunits form the RNR tetramer (69). 
This enzyme responsible for the reduction of ribonucleotide diphosphates to 
deoxyribonucleotide diphosphates (dNDPs) which are subsequently phosphorylated 
by the nucleoside diphosphate kinase to produce the balanced pools of dNTPs 
necessary for DNA synthesis. Outside of an actively dividing cell RRM2 can be 
replaced in the RNR enzyme by the p53 reactive subunit p53R2. This happens most 
often in G0/G1 phase when dNTP usage is typically limited and related to 
mitochondrial DNA replication and repair (69, 70).  A properly regulated and steady 
supply of dNTPs is essential for successful DNA synthesis so activity of the RNR 
enzyme is tightly controlled through the cell cycle. While RRM1 has a long half-life 
and levels stay steady throughout the cell cycle, RRM2 is relatively short lived and is 
transcriptionally regulated in an E2F1 dependent manner, with levels peaking during 
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S-phase (71-73). Outside of S-phase RRM2, is actively degraded through 
proteasome mediated degradation, facilitated by the anaphase promoting 
complex/Cdh1 in G1 (74) and by SCFcyclinF in G2 (75). The increase in RRM2 levels 
during S-phase coincides with an increase in RNR activity at the same time, 
suggesting that RRM2 is the rate limiting component of the RNR enzyme (76, 77). 
Confirming this, a loss of RRM2 results in decreased abundance of dNTPs available 
for DNA synthesis (78, 79). Appropriate RNR activity is important for maintenance of 
genomic integrity and cell viability. An increase or imbalance in dNTP levels can lead 
to mutations (80) while insufficient dNTP pools can impair DNA replication and repair 
(69).  
HPV MAINIPULATION OF THE DNA DAMAGE RESPONSE 
The ATM DDR: Many viruses are known to interact with and manipulate the 
DNA damage response. Replication-coupled recombination is thought to play a role 
in the life cycle of several herpes viruses where activated HR proteins have been 
observed and the MRN complex is even thought to play a role in maintenance of 
latent EBV episomes (81-83). In HPV infected cells, manipulation of the ATM DDR 
and the recruitment of many ATM DDR and HR proteins to viral genomes is known 
to take place throughout the viral lifecycle (84, 85). Importantly, manipulation of the 
ATM regulated HR pathway has been shown to be necessary for productive viral 
amplification upon host cell differentiation (84-86). HPV productive replication is 
known to require the activity of several proteins involved in HR.  One of the first ATM 
DDR proteins discovered to play a role in the HPV lifecycle was the master regulator 
ATM itself (84). Moody and Laimins first observed activated ATM as well as 
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downstream effectors Chk2, and Brca1 in HPV positive cells. In infected cells HPV 
E7 forms a complex with phosphorylated ATM through its LXCXE Rb binding 
domain. In addition, E7 is able to activate Chk2 phosphorylation, possibly through its 
interaction with ATM. This activation of ATM and Chk2 in HPV positive cells was 
sustained upon differentiation, where the downstream substrate Nbs1 was also 
found to be phosphorylated. While not necessary for viral genome maintenance in 
undifferentiated cells, ATM and Chk2 activation were both necessary for successful 
productive viral replication upon differentiation. Interestingly, Chk2 activation upon 
differentiation in these cells is necessary for the caspase 7 activation described 
above, suggesting one possible pathway connecting Chk2 activation with replication 
(84). Furthermore, as previously described, activation of Chk2 by ATM leads to a 
G2/M cell cycle arrest through the cytoplasmic sequestration of CDC25C which 
prevents activation of CDK1. HPV productive replication is believed to occur in a 
G2/M arrested state (87). Therefore, the requirement for ATM activation, specifically 
for productive replication suggests that HPV may be exploiting this pathway in order 
to hold the host cell in a state conducive for productive viral replication.  
Another downstream effector of ATM thought to play a role in the HPV 
lifecycle is the histone variant H2AX. Phosphorylated or H2AX is found associated 
with HPV DNA throughout the viral life cycle and these H2AX foci expand upon 
productive viral replication (58). This association suggest that H2AX may play an 
important role in recruiting HR factors to sites of HPV genome replication. 
Supporting this hypothesis, the deacetylase SIRT1 has been shown to bind at DNA 
damage foci and recruit Nbs1 and 53BP1 in a H2AX mediated manner (88). 
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Upregulation of SIRT1 has been observed in HPV positive cells; this upregulation 
has been shown to be important for the recruitment of Nbs1 and Rad51 to HPV 
genomes and necessary for productive viral replication (89, 90).   
Some viruses, like adenovirus, actively antagonize the MRN complex and 
catalyze its destruction, preventing Nbs1 phosphorylation (91). In contrast, HPV 
infected cells maintain high levels of Mre11, Rad50, and Nbs1 both pre and post 
differentiation (85). This maintenance of MRN components and the phosphorylation 
of Nbs1 observed in differentiating infected cells suggest that Nbs1 may also be 
important in regulation viral replication. Further suggesting the importance of the 
MRN, recently our lab has shown that the HR factors Rad51 and Brca1 are 
necessary for productive viral replication (86). As explained above, the MRN 
complex plays an important role in the recruitment of Rad51 and Brca1 to DNA 
double strand breaks where they are necessary for the completion of HR. 
In addition to HPV E7 interacting with ATM and activating a DNA damage 
response HPV E1 is also capable of activating an ATM dependent DNA damage 
response (3, 59, 92) reviewed in (93). Both the DNA binding and helicase activities 
of E1 have been shown necessary in triggering this response and when both E1 and 
E2 are expressed in a cell they form foci on the host chromatin (3, 59). These results 
suggest that E1 may be triggering a DNA damage response in these cells by melting 
regions of the cellular chromatin around the foci (92). Similar to the foci observed by 
Gillespie et al. in differentiating HPV positive cells these E1-E2 foci recruit members 
of the ATM DDR pathway including pATM, H2AX, pChk2, Nbs1, and Mre11 (3, 58). 
In addition to the observation of the recruitment of these factors, labeled nucleotides 
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were incorporated at these foci, indicating DNA synthesis and/or repair activity (3, 
94). 
The ATR DDR: While manipulation of the ATM DDR pathway by HPV has 
been studied for some time, less is known about HPV engagement of the ATR DDR 
pathway. However, recent studies have presented data suggesting that HPV 
manipulates and requires the ATR DDR throughout its lifecycle (3, 84, 92, 95). It is 
known that expression of the HPV oncogenes E6 and E7 cause replication stress 
(96, 97). This is most likely due to the cell being pushed into S-phase as described 
above, which may trigger DNA replication in the absence of the required materials. 
Previous studies have shown that ATR and Chk1 are constitutively activated in HPV 
positive cells, further suggesting the presence of ongoing replication stress in these 
infected cells (3, 84, 92, 95). Outside the context of a full infection expression of both 
E7 (95) and the viral helicase E1 have been shown to be sufficient to trigger the 
activation of ATR and Chk1 (3, 92). This is important because inhibition of Chk1 has 
been shown to decrease the stability of viral genomes in HPV infected cells prior to 
differentiation (51), and even more recently Chk1 activity has been shown to be 
necessary for viral genome amplification upon differentiation. As stated above ATR 
mediated Chk1 activation has been shown to lead to RRM2 accumulation. Taken 
together these observations suggest that activation of the ATR-Chk1 pathway may 
be another way in which HPV infection increases RRM2 levels in order to insure a 
steady supply of dNTPs for viral DNA synthesis. 
17 
RATIONALE FOR DISSERTATION 
 Due to its small coding capacity and lifecycle being so tightly linked to host 
cell differentiation, HPV has evolved many ways of manipulating the host cell in 
order to recruit and regulate host factors necessary to replicate the viral genome. 
Recently, there has been a great deal of research into how HPV manipulates the 
host cell by targeting the ATM and ATR DDR pathways. In this dissertation I attempt 
to further our understanding of HPV manipulation of these pathways. Specific 
proteins involved in these pathways targeted by the virus are identified along with 
the viral proteins responsible for the manipulation.   
 In the second chapter I focus on the ATM DDR and determine that Nbs1, a 
member of the MRN complex is necessary for productive HPV replication. However, 
despite the fact that Nbs1 is known to play an important role in ATM activation and 
ATM activity is also known to be necessary for productive viral replication, we found 
that depletion of Nbs1 had a minimal effect on ATM activation. Instead, our data 
suggests that Nbs1 is important for productive replication because it recruits HR 
factors such as Mre11 and Rad51 to sites of HPV replication. In fact, we show that 
Mre11 nuclease activity is also necessary for productive viral genome replication. 
 In the third chapter I examine the interaction of the ATR DDR and HPV, a 
considerably less explored topic. We propose a pathway in which RRM2 levels are 
upregulated though the release of E2F1 factors due to Rb degradation and 
stabilization of E2F1 activity through the activation of ATR and Chk1. We believe 
that the observed increase in RRM2 resulted in the increased dNTP pools that we 
measured in HPV positive cells. This lead us to the hypothesis that the virus was 
18 
specifically targeting RRM2 expression through this pathway, in order to provide 
dNTPs for viral genome replication. 
 Hopefully further research into HPV manipulation of these two important 
cellular pathways will lead to a better understanding of how we can control HPV 
replication and spread. Additionally, we may identify strategies to treat the persistent 
HPV infections that are known to be associated with many cancers.  
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CHAPTER 2: PRODUCTIVE REPLICATION OF HUMAN PAPILOMAVIRUS 31 
REQUIRES THE DNA REPAIR FACTOR NBS11  
 
OVERVIEW 
Activation of the ATM (Ataxia telangiectasia-mutated kinase)-dependent DNA 
damage response (DDR) is necessary for productive replication of Human 
Papillomavirus 31 (HPV31). We previously found that DNA repair and homologous 
recombination (HR) factors localize to sites of HPV replication, suggesting ATM 
activity is required to recruit factors to viral genomes that can productively replicate 
viral DNA in a recombination-dependent manner. The Mre11-Rad50-Nbs1 (MRN) 
complex is an essential component of the DDR that is necessary for ATM-mediated 
HR repair, and localizes to HPV DNA foci. In this study, we demonstrate that the 
HPV E7 protein is sufficient to increase levels of the MRN complex, and also 
interacts with MRN components. We have found that Nbs1 depletion blocks 
productive viral replication, and results in decreased localization of Mre11, Rad50, 
and the principal HR factor Rad51 to HPV DNA foci upon differentiation. Nbs1 
contributes to the DDR by acting as an upstream activator of ATM in response to 
double strand DNA breaks (DSB), and as a downstream effector of ATM activity in
                                                          
1 This chapter previously appeared as an article in the Journal of Virology.  The 
original citation is as follows: Anacker DC, Gautam D, Gillespie KA, Chappell WH, 
Moody CA. 2014. Productive replication of human papillomavirus 31 requires DNA 
repair factor Nbs1. J Virol 88:8528–8544. 
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the intra-S phase checkpoint.  We have found that phosphorylation of ATM and its 
downstream target Chk2, as well as SMC1 (structural maintenance of chromosome 
1) is maintained upon Nbs1 knockdown in differentiating cells.  Given that ATM and 
Chk2 are required for productive replication, our results suggest that Nbs1 
contributes to viral replication outside of its role as an ATM activator, potentially 
through ensuring localization of DNA repair factors to viral genomes that are 
necessary for efficient productive replication.  
 
INTRODUCTION 
Human papillomavirus are small double stranded DNA viruses that exhibit a 
strict tropism for epithelial cells (1). A subset of HPV types (termed high-risk) are the 
causative agents of cervical cancer, and are also associated with other genital 
malignancies, as well as an increasing number of head and neck cancers (2). The 
life cycle of HPV is dependent upon the differentiation of its host cell, the 
keratinocyte.  There are three phases of viral replication that characterize the viral 
life cycle (3).  Upon infection of basal keratinocytes, the virus transiently amplifies to 
50-100 episomal copies per cell. In undifferentiated cells, the virus is maintained at a 
low copy number by replicating once per cell cycle along with cellular DNA (4). In 
contrast, upon keratinocyte differentiation, the productive phase of the viral life cycle 
is activated, resulting in late gene expression, viral genome amplification to 
thousands of copies per cell, virion assembly and release (1).  Viral genome 
amplification is thought to occur through multiple rounds of replication following 
cellular DNA synthesis in cells arrested in an S- or G2-like environment (5-8), with 
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some evidence indicating this occurs through a switch to rolling circle replication (9).  
Although it is well established that the viral E7 protein promotes S phase re-entry of 
differentiating cells to provide cellular factors necessary for productive replication 
(10), the mechanisms that regulate the switch to viral genome amplification in 
differentiating cells are not well understood.  
Over the past several years, it has become evident that DNA and RNA 
viruses facilitate replication by targeting the DNA damage response (11). Previously, 
we showed that high-risk HPV31 induces constitutive activation of an ATM-
dependent DNA damage response throughout the viral life cycle (12).  ATM is a 
member of the phosphatidylinositol 3-kinase-like kinases (PIK) family of kinases, 
which along with ATR (Ataxia telangiectasia and Rad3-related protein) and DNA-PK, 
respond to certain types of DNA damage (13).  ATM and DNA-PK are typically 
activated in response to double strand DNA breaks (DSB), while ATR is activated in 
response to single stranded DNA breaks, as well as replication stress. Our previous 
studies demonstrated that HPV31 requires ATM kinase activity for productive 
replication upon differentiation, but not for episomal maintenance in undifferentiated 
cells (12). In HPV31 positive cells, the ATM response was characterized by 
phosphorylation of downstream targets, including Chk2, Nbs1 and Brca1 (12). 
Similarly to inhibition of ATM, Chk2 inhibition also blocked productive replication, 
indicating an important role for ATM signaling specifically during the differentiation-
dependent phase of the viral life cycle.  How HPV activates ATM is currently unclear, 
though we have found that E7 expression alone is sufficient to induce activation of 
ATM targets (12), possibly through the induction of replication stress and DNA 
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damage (14, 15).  Recent studies by Hong and Laimins demonstrated that E7-
induced STAT5 activation is necessary for ATM activation, possibly through PPAR 
expression (16). We, as well as others, have shown that expression of viral helicase 
E1 can also stimulate ATM activation (8, 17). Why HPV requires ATM activity for 
productive replication, as well as which ATM effectors contribute to viral DNA 
synthesis is not well understood.  
In more recent studies, we demonstrated that multiple components of the 
ATM DNA damage response pathway localize to sites of HPV replication, including 
H2AX, Chk2, 53BP1 and components of the MRN complex (Mre11, Rad50, Nbs1) 
(18). In addition, we found that Rad51 and Brca1, two proteins necessary for the 
repair of DSBs through homologous recombination (HR) (19), are increased in 
expression in HPV positive cells and localize to viral DNA foci. The localization of 
cellular replication factors, PCNA and RPA32, to HPV DNA foci indicated these were 
sites of viral DNA synthesis. In addition, we observed that RPA32 is phosphorylated 
at sites of HPV replication, which is thought to redirect RPA’s function from DNA 
replication to repair synthesis, and has been linked to DSB resection (20-22). This 
suggests that HPV may utilize ATM signaling to recruit DNA repair machinery to viral 
genomes to promote replication through DNA repair. In support of this, we found that 
H2AX is bound to viral chromatin throughout the viral life cycle, with binding 
increasing upon productive replication (18). 
Increasing evidence suggests a role for recombination in HPV replication 
(23).  Indeed, the localization of Rad51 and Brca1 to sites of HPV DNA synthesis 
suggests that productive replication may result in structures that require HR for 
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processing.  HR is a high-fidelity repair mechanism that requires ATM activity and 
functions to rejoin DSBs and restart broken replication forks (19, 24).  Replication-
coupled recombination is thought to play role in the life cycle of several viruses, 
including Simian Virus 40 (SV40) (25), Herpes Simplex Virus type 1 (HSV-1) (26-
28), Epstein Barr virus (EBV) (29, 30), and Kaposi’s Sarcoma Associated 
Herpesvirus (KSHV) (31). The MRN complex is also essential to homology-directed 
repair (32). The MRN complex serves as a sensor of DNA damage that also controls 
the DDR through activation of ATM (33-35).  ATM is recruited to sites of DSBs by 
directly binding Nbs1, where ATM activates the DNA damage checkpoint and 
regulates DNA repair by phosphorylating specific substrates (36-38). In addition to 
facilitating ATM activation and recruitment to DSBs, Nbs1 also acts downstream as 
an effector of ATM activity, and initiates HR with Mre11, a nuclease involved in 
resection of DNA ends (22, 39).  The importance of Nbs1 is facilitating DNA repair is 
evident in patients with Nijmegen breakage syndrome (NBS), a disorder due to 
hypomorphic mutations in the Nbs1 gene, which is characterized by cellular 
radiosensitivity, cell cycle abnormalities and a defective response to DNA damage 
(40-42). Several viruses have been shown to relocalize and/or degrade components 
of the MRN complex to facilitate viral replication (11). In addition, the SV40 Large T 
antigen (43), as well as the HSV protein UL12 (44) has been shown to interact with 
MRN components. Our previous studies demonstrated that HPV positive cells 
exhibit high levels of MRN components throughout the viral life cycle (12), which 
may be important in HPV’s ability to activate ATM, and therefore contribute to 
efficient of viral replication upon differentiation. 
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In this study, we investigate whether Nbs1 and maintenance of the MRN 
complex has an impact on the ability of HPV to efficiently replicate. We report here 
that HPV31 and HPV16 E7 bind to the MRN components Nbs1 and Rad50, but not 
Mre11.  However, formation of the MRN complex is not disrupted, and rather is 
increased compared to uninfected keratinocytes. We have found that Nbs1 is 
required productive viral replication, but not episomal maintenance.  Depletion of 
Nbs1 results in a loss of Mre11, Rad50 as well as Rad51 from sites of viral 
replication upon differentiation, suggesting that productive replication may occur 
through a mechanism dependent on recombination. Although phosphorylation of 
ATM and Chk2 are decreased in the absence of Nbs1, relatively high levels remain 
during the productive phase of the viral life cycle. Importantly, our results indicate 
that Nbs1 does not contribute to productive viral replication solely as an upstream 
regulator of ATM activity, but rather has functions downstream as well, with Nbs1 
potentially acting as an effector of ATM activity and/or ensuring efficient viral DNA 
synthesis through a recombination-dependent mechanism. 
MATERIALS AND METHODS 
Cell culture. Human foreskin keratinocytes (HFKs) were collected from 
neonatal foreskin tissue as described previously (45) and were maintained in 
Dermalife keratinocyte growth media (KGM; Lifeline Cell Technology). The human 
cervical carcinoma cell line C33A was grown in DMEM supplemented with 10% 
bovine growth serum (BGS) (Life Technologies). CIN612 9E cells, which are derived 
from a CIN1 biopsy and stably maintain HPV31 genomes, were grown in in E-media 
supplemented with 5ng/mL mouse epidermal growth factor (BD Biosciences) and 
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co-cultured with mitomycin C treated J2 3T3 fibroblasts, as described previously 
(45). The NBS-ILB1 fibroblast cell line was a generous gift from K. Cerosaletti, and 
was described previously (46). NBS-ILB1 cells were maintained in DMEM with 
sodium pyruvate supplemented with 10% BGS. Generation and maintenance of cells 
stably expressing pLXSN or pLXSN-HPV31 E7, pLXSN-HPV16 E7 through retroviral 
transduction has been previously described (47). When necessary, J2 feeders were 
removed from HPV positive cells by incubating with Versene (PBS containing 1mM 
EDTA). U20S and 293T cells were grown in DMEM supplemented with 10% BGS. 
 
Plasmids and Chemicals. The pBR322min-HPV31 plasmid has been 
described previously (48).  The HA-tagged HPV31 E7 proteins were previously 
described (49) and are as follows: HA-E7 LHCYE contains an in-frame deletion of 
the Rb binding domain, and the HA-E7 L67R construct contains a point mutation in 
the HDAC binding site, converting a leucine to an arginine.  The TAP-tagged HPV16 
E7 construct was generously provided by J. Bodily, and was described previously 
(50). The retroviral plasmids pLXIN, pLXIN-Nbs1, and those expressing Nbs1 
truncation mutants (Nbs1 652 and Nbs1 ATM) were kind gifts from P. Concannon, 
and were described previously (51, 52). The pLXIN-Nbs1 FR5 deletion construct 
was obtained from K. Cerosaletti and was described previously (52). The Mre11 
binding mutant was also obtained from K. Cerosaletti, and was generated by site-
directed mutagenesis (QuikChange, Agilent Technologies) based on the 
identification of the Mre11 binding domain by You et al (53), resulting in a NFKK684-
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687AAAA conversion. KU-55933 was obtained from Calbiochem, and MIRIN was 
obtained from TOCRIS.  
 
Generation of HPV 31 positive HFKs. HFKs stably maintaining HPV31 
episomes were created as previously described (45). Briefly, HPV31 genomes were 
excised from the pBR322 plasmid using HindIII (New England Biolabs) and religated 
using T4 DNA ligase (Life Technologies). Primary HFKs were transfected with 1ug of 
the ligated genomes and 1ug pSV2-Neo using FuGene 6 according to manufactures 
instructions (Promega). Stable cell lines were generated through neomycin selection 
(Sigma-Aldrich). After selection was complete, pooled populations were expanded 
for further analysis. 
 
Induction of Keratinocyte Differentiation. For differentiation, 1.5% 
methylcellulose was used as described previously (54). Cells were harvested at T0 
(undifferentiated), as well as 24 and 48 hours post-suspension. High calcium 
medium was also used to induce differentiation as previously described (7). Cells 
were harvested at T0, as well as 48, 72 or 96hr post-exposure to high calcium. For 
both methylcellulose and calcium, at each time point DNA was harvested from one 
half of the cells, and protein was harvested from the other half. For every 
experiment, viral genome amplification was measured by Southern blot analysis to 
ensure activation of the productive phase of the viral life cycle.  
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Generation of Lentivirus. Lentivirus was produced as previously described 
(55). Plasmids encoding a Nbs1 shRNA (TRCN0000010393) or a scramble non-
target control shRNA in the pKLO background were obtained from Open Biosystems 
(Pittsburg, PA).  Each of these plasmids (5ug) was co-transfected with 1.6ug 
vesicular stomatitis virus G plasmid DNA, and 3.37ug Gag-Pol-Tet-Rev plasmid 
DNA into 293T cells using polyethyleneimine (PEI) (VWR). Supernatants containing 
lentivirus were harvested three days post-transfection, filter sterilized, and stored at -
80°C until use. CIN612 9E and HFK-31 cells were transduced with 5ml viral 
supernatant consisting of Scramble or Nbs1 shRNA lentivirus particles in the 
presence of 4.8ug/mL hexadimethrine bromide (Polybrene) (Sigma-Aldrich) for three 
days, followed by selection in puromycin to generate stable cell lines. Knockdown of 
Nbs1 was confirmed for each experiment by Western blot analysis. 
 
Nuclear/Cytoplasmic Fractionation. Fractionation was carried out 
according to the methods of Schreiber et al (56). Briefly, after washing in cold PBS, 
cells were resuspended in 400uL Schreiber buffer A (10mM HEPES, 0.4M NaCl, 
0.1mM EDTA, 0.1mM EGTA, 1mM DTT, 0.5mM PMSF) and swollen on ice for 15 
minutes. The cells were then lysed by the addition of 25ul 10% NP-40 and vortexing 
for 10 seconds. The nuclei were subsequently pelleted by centrifugation at 4˚C. The 
supernatant containing the cytoplasmic extract was removed and the nuclei were 
lysed by addition of 50ul Schreiber buffer C (20mM HEPES, 10mM KCl, 0.1mM 
EDTA, 0.1mM EGTA, 1mM DTT, 0.5mM PMSF) and shaking for 15 minutes at 4˚C. 
The soluble nuclear fraction was separated by centrifugation for 5 min at 4˚C. Purity 
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of nuclear and cytoplasmic fractions was determined by Western blot analysis using 
antibodies to Lamin A/C (Genetex) and Tubulin (Sigma-Aldrich), respectively.  
 
Western blot analysis/Immunoprecipitation. For Western blotting, whole 
cell lysates were harvested in RIPA lysis buffer supplemented with Complete Mini 
and PhosSTOP tablets (Roche). Total protein levels were determined via Bio-Rad 
protein assay. Western blot analysis was performed as described previously (49). 
Equal protein amounts were electrophoresed on SDS-polyacrylamide gels and 
transferred to polyvinylidene difluoride membranes (Immobilon-P; Millipore). For 
immunoprecipitations, cells were harvested in 1X cell lysis buffer (Cell Signaling), as 
described previously (12).  The following primary antibodies were used: anti-mouse 
HA, anti-rabbit HA, anti-goat Nbs1, anti-mouse involucrin, anti-mouse Ku70, anti-
mouse CDC25C, anti-mouse Cyclin A, anti-rabbit Cyclin B, anti-rabbit RPA32, anti-
mouse GAPDH (Santa Cruz); anti-mouse Cyclin E (Pharmingen); anti-mouse 
HPV16 E7 (Life Technologies); anti-rabbit Nbs1, phospho-Nbs1 S343 (Novus 
Biologicals); anti-rabbit phospho-ATM S1981 and anti-mouse CDK2, anti-rabbit 
PCNA (Abcam); anti-rabbit phospho-Chk2 Thr68 and Chk2, anti-rabbit CDK1, and 
anti-rabbit SMC1 (Cell Signaling Technologies); anti-rabbit ATM, anti-rabbit 
phospho-SMC1 Ser966 (Bethyl Laboratories); anti-mouse Lamin A/C, anti-mouse 
Mre11 and anti-rabbit Rad50 (Genetex); anti-mouse Tubulin (Sigma-Aldrich). 
Secondary antibodies used were: HRP conjugated anti-goat (Santa Cruz), HRP 
conjugated anti-rabbit (Cell Signaling Technologies), and HRP conjugated anti-
mouse (GE Life Sciences).  
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Southern Blot analysis. DNA isolation and Southern blotting were 
performed as previously described (54). Briefly, cells were harvested in buffer 
containing 400mM NaCl, 10mM Tris pH 7.5 and 10mM EDTA. Cells were lysed by 
the addition of 30uL 20% SDS and subsequently treated with 15ul of 10mg/mL 
proteinase K overnight at 37˚C. DNA was then extracted by phenol chloroform and 
precipitated using sodium acetate and ethanol. Resultant DNAs were digested with 
BamHI (which does not cut the HPV31 genome) or HindIII (which cuts the HPV31 
genome once). DNAs were resolved on a 0.8% agarose gel and transferred to a 
positively charged nylon membrane (Genescreen plus; Perkin Elmer). Hybridization 
was performed using 32P-labeled HPV31 genome as a probe.  
 
Immunofluorescence (IF) and Fluorescence in situ hybridization (FISH). 
CIN612 9E cells stably expressing the scramble or Nbs1 shRNA were grown on 
coverslips and harvested at T0 or 72 hours following differentiation in high calcium.  
At the indicated times, the cells were fixed with 4% paraformaldehyde (PFA) for 10 
minutes, then permeabilized with 1% Triton-X 100 in phosphate buffered saline 
(PBS) for 10 minutes, followed by three washes with PBS. Cover slips were blocked 
with 3% bovine serum albumin (BSA) in PBS for 30 minutes and incubated with 
primary antibodies in 3% BSA-PBS overnight at 4C in a humidified chamber. Cover 
slips were washed three times with PBS and incubated with secondary antibodies 
for one hour followed by three washes with PBS. Cover slips were cross-linked with 
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cold methanol:acetic acid (3:1) at -20C for 10 minutes followed by fixation with 4% 
PFA for 10 minutes at room temperature. Cover slips were then analyzed for HPV 
DNA by FISH using Tyramide-enhanced fluorescence (Invitrogen) as previously 
described(12, 57). The coverslips were mounted using Vectashield containing DAPI 
to counterstain the cellular DNA. Images were captured using Zeiss CLSM 710 
spectral confocal laser scanning microscope. For IF, the following antibodies were 
used: mouse monoclonal anti-Mre11 (1:200; GeneTex), mouse monoclonal anti-
Rad50 (1:200; GeneTex), and rabbit polyclonal Rad51 (1:200; Santa Cruz). For the 
secondary antibody, Alexa Fluor® 568 Goat Anti-Mouse was used (Life 
Technologies). IF/FISH was carried out for each repair factor on three independent 
experiments. The number of foci positive for both HPV DNA and each repair factor 
was quantified, with 25 to 40 FISH-positive cells being counted for each experiment.   
 
Real-time PCR. RNA was isolated from HFKs, as well as HFKs stably 
expressing pLXSN-HPV 31 or -HPV16 E7 using RNA STAT 60 (Tel-Test), followed 
by treatment with DNase (Promega) according to the manufacturer instructions. 
RNA was reverse transcribed using the iScript reverse transcription kit (Biorad).  50 
nanograms of cDNA was analyzed in triplicate reactions using qPCR with 375nM 
primers and iTaq Universal SYBR Green Supermix (Bio-Rad) in a total reaction 
volume of 20ul. Reactions were carried out in an ABI 7500 thermal cycler with a 
thermal profile of 3 min at 95C, 40 cycles of 95C for 15 seconds, then 30 seconds 
at 60C, followed by a melting curve to ensure proper annealing. The results were 
analyzed using version 2.0.5 of the ABI 7500 software application.  The following 
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gene specific primer sequences were used: Mre11 (Forward 5’- 
GCCTTCCCGAAATGTCACTA -3’; Reverse 5’- TTCAAAATCAACCCCTTTCG -3’), 
Rad50 (Forward 5’- GGAAGAGCAGTTGTCCAGTTACG -3’; Reverse 5’- 
GAGTAAACTGCTGTGGCTCCAG -3’), Nbs1 (Forward 5’- 
CACCTCCAAAGACAACTGCGGA -3’; Reverse 5’- 
TCTGTCAGGACGGCAGGAAAGA -3’), GAPDH (Forward 3’- 
CTGTTGCTGTAGCCAAATTCGT -5’; Reverse 3’- ACCCACTCCACCTTTGAC -5’). 
Relative transcript amounts were calculated using the CT method using GAPDH 
as a reference gene.  
 
RESULTS 
Expression of high-risk HPV E7 increases levels of repair factors, 
including the MRN complex.  Previously we demonstrated that HPV31 E7 is 
sufficient to induce phosphorylation of the ATM target Chk2 (12). To determine if this 
observation extends to HPV16 E7, we examined Chk2 phosphorylation in human 
foreskin keratinocytes (HFK) stably expressing pLXSN-HPV16 E7 or vector control. 
As shown in Figure 2.1A, we found the expression of HPV16 E7, similarly to HPV31 
E7 (Figure 2.1B), is sufficient to induce Chk2, as well as Nbs1 phosphorylation, and 
also significantly increase total levels of Chk2 (Figure 2.1C, D).  Our previous 
studies also revealed that the MRN components Mre11, Rad50 and Nbs1 are 
expressed at increased levels in HPV positive cells compared to uninfected 
keratinocytes (12). To determine if E7 could be responsible for increased levels of 
the MRN components in infected cells, we examined the levels of Mre11, Rad50 and 
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Nbs1 in keratinocytes stably expressing HPV16 E7 or HPV31 E7.  As shown in 
Figure 2.1, expression of both HPV16 E7 and HPV31 E7 resulted in a significant 
increase in protein levels of Mre11, Rad50 and Nbs1, however the repair proteins 
Ku70 and SMC1 were not affected (Figure 2.1 A-D).  To determine if the increase in 
MRN components was regulated transcriptionally, we performed quantitative real-
time PCR on RNA extracted from HFKs stably expressing HPV31 E7 or vector 
control.  As shown in Figure 2.1E, although expression of HPV 31E7 resulted in 
increased transcript levels of Mre11 and Nbs1, only Mre11 was significantly 
changed. In contrast, Rad50 was significantly decreased at the transcript level in 
HPV31 E7 cells compared to the vector control. Since Mre11 stabilizes Rad50 and 
Nbs1 through binding (58, 59), it is possible that the E7-mediated increase in Mre11 
transcript and protein levels is sufficient to maintain elevated levels of Rad50 and 
Nbs1. Overall, these results suggest that in addition to activation of ATM signaling, 
E7 may be necessary to provide essential DNA repair factors for viral replication.   
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Figure 2.1. Expression of HPV E7 increases levels of proteins associated with 
detection and repair of DNA damage. (A) Whole cell extracts were harvested from 
HFKs stably expressing pLXSN vector control or pLXSN-HPV16 E7. Immunoblotting 
was performed using antibodies to phosphorylated Chk2 (Thr68) (pChk2), total 
Chk2, phosphorylated Nbs1 S343 (pNbs1), total Nbs1, Rad50, Ku70 and SMC1. (B) 
Lysates harvested from HFK-pLXSN or HFK-pLXSN HPV31 E7 cells were analyzed 
by Western blot analysis using antibodies to pChk2, Chk2, Nbs1, Rad50, Mre11, 
Ku70 and SMC1. GAPDH served as a loading control. (C, D) Bar graphs 
demonstrate the average expression level of target proteins, normalized to GAPDH, 
in at least four independent Western blot analyses, including data from Panel A and 
B. Densitometry was performed using ImageJ software. The statistical analysis was 
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assayed by 2-tailed t-test. Data=mean +/- standard error. ** indicates p-value less 
than 0.05. (E) Quantitative real-time (qRT) PCR of gene expression analysis in HFK-
pLXSN and HFK-pLXSN-31E7 lines. Expression levels are shown relative to HFK-
pLXSN cells and were calculated using GAPDH serving as a reference gene. Shown 
is the relative fold change in gene expression over three independent experiments. 
The statistical analysis was assayed by 2-tailed t-test. Data= mean +/- standard 
error. ** indicates p-value less than 0.05.  
 
E7 binds to the MRN components Nbs1 and Rad50. In previous studies, 
we found that HPV31 E7 binds preferentially to the phosphorylated form of ATM 
(12), potentially due to the exposure of the E7 binding site upon dissociation of 
inactive ATM dimers to active monomers.  Since Nbs1 binds ATM for recruitment to 
DSBs, we wanted to determine if E7 also binds Nbs1. For this, we 
immunoprecipitated HA tagged HPV31 E7 from transiently transfected U20S cells, 
and performed Western blotting for endogenous Nbs1.  As shown in Figure 2.2A, 
Nbs1 co-immunoprecipitates with HPV31 E7, and we found similar results when 
endogenous Nbs1 was immunoprecipitated, followed by Western blot analysis for 
HPV16 E7 (Figure 2.2B) or HPV31 E7 (Figure 2.2D, 2E). The E7/Nbs1 interaction 
does not appear to occur nonspecifically through DNA, as immunoprecipitation in the 
presence of ethidium bromide did not affect the ability of E7 to bind Nbs1 (data not 
shown). 
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In order to map the Nbs1 interaction domain on HPV31 E7, we used 
previously characterized mutants that block either the binding of Rb (LHCYE) or 
histone deacetylases (HDACs) (L67R) (Figure 2.2C) (49). As shown in Figure 2.2D, 
both the E7 Rb binding mutant and the HDAC binding mutant were deficient in 
immunoprecipitating Nbs1. Since we previously found ATM also binds E7 through 
these two domains (12), we wanted to next determine if E7 interacts with Nbs1 
indirectly through its binding to ATM.  For this, we treated cells with the small 
molecule inhibitor of ATM, KU-55933, which inhibits ATM phosphorylation and 
ablates the ability of E7 to bind ATM (Figure 2.2E) (12).  However, we found that 
Nbs1 was still able to immunoprecipitate E7, even when the E7/ATM interaction was 
disrupted (Figure 2.2E), indicating that E7 binds Nbs1 independently of ATM.  
 
Figure 2.2. HPV E7 interacts with Nbs1 independently of ATM. (A) Whole cell 
lysates of U20S cells transiently transfected with HA-HPV31 E7 or empty vector 
(EV) were immunoprecipitated with antibodies to HA or Nbs1, followed by 
immunoblotting with an antibody to Nbs1 or HA. (B) Whole cell lysates of U20S cells 
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transiently transfected with TAP-HPV16 E7 or empty vector (EV) were 
immunoprecipitated using an anti-Nbs1 antibody, followed by immunoblotting with an 
HPV16 E7 antibody. Inputs were analyzed using antibodies to (A) Nbs1 and HA, and 
(B) Nbs1 and HPV16E7. (C) Structure of E7 and mutations examined in this study. 
Indicated are cellular targets that have been shown to interact with the Rb (LHCYE) 
and HDAC (L67) binding domains(97). (D) Whole cell lysates of U20S cells 
transiently transfected with EV alone, HA-HPV31 E7, HA-31 E7 LHCYE, or HA-31 
E7 L67R were immunoprecipitated using an anti-Nbs1 antibody and subsequently 
immunoblotted using an anti-HA or anti-Nbs1 antibody. Input lysates were analyzed 
by Western blot analysis using antibodies to HA and Nbs1. (E) Whole cell lysates of 
U20S cells expressing EV alone, or HA-HPV31 E7 in the presence or absence of 
10uM the ATM inhibitor KU-55933 were immunoprecipitated using an anti-Nbs1 
antibody and immunoblotted using an anti-HA antibody (left panel). Input lysates 
were immunoblotted with antibodies to Nbs1, HA, as well as phosphorylated ATM 
(Ser1981) and total ATM to demonstrate ATM inhibition. Lysates were also 
subjected to immunoprecipitation with an antibody to HA, followed by 
immunoblotting to ATM and HA. Inputs were analyzed using an antibody to HA, as 
well as phosphorylated and total ATM to demonstrate ATM inhibition. Ab=antibody. 
IP=immunoprecipitation. W=immunoblotting. ATMi=KU-55933. All results are 
representative of observations of three or more independent experiments. 
  
To map the HPV31 E7 interaction site on Nbs1, we utilized a series of 
previously characterized Nbs1 deletion mutants (Figure 2.3A) (51, 52). For these 
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studies we used the NBS-ILB1 fibroblast cell line that is hypomorphic for Nbs1 and 
produces undetectable levels of a 70-kDa C-terminal polypeptide (46, 60).  NBS-
ILB1 cells were retrovirally transduced with wild-type (WT) Nbs1, a mutant that lacks 
the C-terminus (Nbs1 652), a mutant that lacks the N-terminus (FR5) or a mutant 
that lacks the ATM binding site (ATM), and stable cell lines were generated through 
neomycin selection.  Immunoprecipitation of Nbs1 from lysates of cells containing 
the pLXIN vector, WT Nbs1 or the mutants revealed that the C-terminus of Nbs1 is 
required to immunoprecipitate E7 (Figure 2.3B).  Importantly, we found that E7 was 
still able to co-immunoprecipitate with the Nbs1 mutant lacking the ATM binding 
domain, confirming our results with the ATM inhibitor (Figure 2.3B). The C terminus 
of Nbs1 contains an Mre11 binding domain (52, 53), in addition to an ATM binding 
site (38, 53, 61).  To determine if the Mre11 binding domain of Nbs1 is required for 
immunoprecipitation of E7, we utilized a construct that is mutated in the Mre11 
binding site.  As shown in Figure 2.3C, mutation of the Mre11 binding site abrogated 
the ability of E7 to immunoprecipitate with Nbs1, suggesting that E7 interacts with 
Nbs1 through the Mre11 binding domain, though it is currently unclear if this occurs 
in a direct or indirect manner. 
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Figure 2.3. HPV 31 E7 interacts with Nbs1 through the Mre11 binding domain. 
(A) Schematic of Nbs1 constructs depicting relevant binding domains and 
phosphorylation sites. (B) NBS-ILB1 cells stably expressing pLXIN vector alone, or 
the indicted Nbs1 mutants were transiently transfected with HA-HPV31 E7.  
Immunoprecipitations were performed using an antibody to Nbs1, followed by 
Western blot analysis using an antibody to HA. Western blot analysis was performed 
on the indicated input lysates using antibodies to HA, Nbs1 and GADPH. (C) NBS-
ILB1 cells stably expressing pLXIN vector alone, pLXIN-Nbs1, or a pLXIN-Nbs1 
Mre11 binding mutant (Mre11 BM) were transiently transfected with HA-HPV31 E7. 
Immunoprecipitation of whole cell lysates was performed using an antibody to Nbs1 
followed by Western blot analysis with an antibody to HA and Mre11. Western blot 
analysis was performed on the indicated input lysates using antibodies to HA, Nbs1, 
Mre11 and GADPH. IP=immunoprecipitation. W=immunoblotting. All results are 
representative of observations of three independent experiments. 
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To form the MRN complex, Nbs1 binds Mre11, which binds to Rad50 (40, 62). 
Since we were able to immunoprecipitate Nbs1 with E7, we next wanted to 
determine if E7 interacts with other components of the MRN complex. For this, we 
immunoprecipitated HA-tagged HPV31 E7 or TAP-tagged HPV16 E7 from lysates 
harvested from U20S cells, and performed Western blot analysis for Mre11 and 
Rad50.  Interestingly, as shown in Figure 2.4A, we found that both HPV31 E7 and 
HPV16 E7 could immunoprecipitate with Rad50, but neither interacted with Mre11.  
However, we found that the presence of E7 did not disrupt formation of the MRN 
complex, as Nbs1 was still able to interact with Rad50 and Mre11 (Figure 2.4B). 
Rather, our results indicate that the presence of E7 increases the formation of the 
MRN complex, which may result from increased Mre11 expression. We also found 
that the formation of the MRN complex is not disrupted in HPV infected cells (Figure 
2.8B) or cells stably expressing HPV31 E7 (data not shown).  
 
Figure 2.4. HPV E7 interacts with Nbs1 and Rad50, but not Mre11. (A) U20S 
cells were transiently transfected with vector alone (EV), HA-HPV31 E7, TAP-
HPV16 E7, and immunoprecipitations of whole cell lysates were performed using an 
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HA antibody, followed by immunoblotting with Mre11, Rad50, and Nbs1 antibodies. 
(B) U20S cells were transiently transfected with EV alone, HA-HPV31 E7 or TAP-
HPV16 E7. Immunoprecipitations were performed on lysates using an antibody to 
Nbs1, followed by Western blot analysis using antibodies to Mre11, Rad50, and 
Nbs1 antibodies. For (A) and (B), input lysates were analyzed by Western blot 
analysis using antibodies to HA, Mre11, Rad50 and Nbs1. GAPDH served as a 
loading control. IP=immunoprecipitation. * = antibody heavy chain. All results are 
representative of observations of three independent experiments. 
Nbs1 is necessary for productive viral replication. Previously, we 
demonstrated that inhibition of ATM kinase activity has minimal effect on the ability 
of HPV to be maintained as an episome (12). However, in addition to being essential 
for ATM activation in response to DSBs, Nbs1 can also mediate ATR activation (63, 
64), which could potentially be important for episomal maintenance. To examine the 
effect of Nbs1 depletion on episomal maintenance, we transduced HPV31 positive 
CIN612 9E cells with a scramble control shRNA or a previously validated Nbs1 
shRNA (65), and generated stable cell lines. The cells were routinely passaged, and 
DNA and protein were harvested at every passage.  Southern blot analysis was 
performed to examine the status of the episomal viral DNA.  As shown in Figure 2.5 
and Figure 2.12A, in two independently derived CIN612 9E lines, there was no 
significant difference in the ability of viral episomes to be maintained across 
passages in cells containing either the scramble control or the Nbs1 shRNA. Similar 
results were observed with four independent experiments (Figure 2.5B). These 
results mirror what we previously observed upon inhibition of ATM activity, and 
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indicate that Nbs1 is not necessary for episomal maintenance. In addition, we 
observed no effect of Nbs1 knockdown on Chk1 phosphorylation (data not shown).  
 
Figure 2.5. Nbs1 is not necessary for HPV31 genome maintenance. (A) DNA 
was isolated at the indicated passages from CIN612 9E cells stably maintaining a 
scramble shRNA (shScram) or Nbs1 shRNA (shNbs1) and analyzed by Southern 
blot analysis. Passage 22 (p22) represents the passage at which the CIN612 9E 
cells were transduced with the respective shRNAs.  Each passage following 
transduction is represented by p22-#. Western blot analysis was performed on 
lysates harvested at each passage using an antibody to Nbs1 to demonstrate 
knockdown, as well as antibodies to Mre11 and Rad50.  GAPDH served as a 
loading control. IB=immunoblotting. (B) Bar graph represents episome copy number 
quantified and averaged across the passages of Scramble shRNA (set at 1) 
containing cells compared to passages of Nbs1 shRNA containing cells. The data 
represent the average of four independent experiments. Densitometry was 
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performed using ImageJ software. The statistical analysis was assayed by 2-tailed t-
test. Data=mean +/- standard error. 
 
Since we previously found that ATM activity is necessary for productive viral 
replication, and given that Nbs1 is necessary for ATM activation in response to 
DSBs (32, 35, 36), we next wanted to determine the effect of Nbs1 depletion on 
productive replication. For this, CIN612 9E cells stably maintaining the scramble or 
Nbs1 shRNAs were induced to differentiate in high calcium medium, which activates 
the productive phase of the viral life cycle by 48 hours post-exposure (66). As shown 
in Figure 2.6A, Southern blot analysis for HPV DNA demonstrated that cells 
containing the Nbs1shRNA were greatly inhibited in their ability to undergo viral 
genome amplification compared to the scramble shRNA control, exhibiting a 
decrease in episomal copy number upon differentiation. This experiment was 
performed at least three times with three independently derived CIN612 9E lines 
with similar results.  In addition, we found Nbs1 knockdown also decreased 
productive replication of human foreskin keratinocytes stably maintaining HPV31 
genomes (HFK-31) after differentiation in methylcellulose (Figure 2.6C).  Importantly, 
Nbs1 knockdown did not inhibit the ability of HPV positive cells to differentiate in 
high-calcium or methylcellulose as indicated by the expression of the differentiation-
specific marker, involucrin (Figure 2.6B, D).  In addition, as shown in Figure 2.7, 
Nbs1 knockdown had minimal effect on the level of cellular factors involved in 
replication and cell cycle regulation, including the S phase cyclins (cyclin A and 
cyclin E) and CDK (CKD2) (Figure 2.7A), as well as mitotic cyclin B, the M-phase 
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CDK (CDK1), and the CDC25C phosphatase (Figure 2.7B). In addition, both RPA 
and PCNA were maintained at similar levels in the Nbs1 shRNA cells compared to 
the scramble control (Figure 2.7C).  These results suggest that the block in 
productive viral replication observed in response to Nbs1 knockdown was not due to 
alterations in cell cycle control or the lack of cellular factors directly required for viral 
replication. We also observed similar effects on productive viral replication following 
transient knockdown of Nbs1 for three days (data not shown). Overall, these results 
indicate that Nbs1 is specifically necessary for differentiation-dependent viral 
replication.   
 
Figure 2.6. Nbs1 is necessary for productive viral replication. (A) DNA was 
harvested from CIN612 9E cells stably expressing a scramble shRNA or Nbs1 
shRNA at T0 (undifferentiated) or after 48 and 96hr differentiation in high calcium 
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medium. Southern blot analysis was performed to analyze viral genome 
amplification. The bar graph represents quantification of the episome copy number 
present at each time point, relative to T0 shScramble, which was set to 1. 
Densitometry was performed using ImageJ. Ca=calcium. (B) Total protein was 
harvested from CIN612 9E shScramble and shNbs1 cells at T0 or after 48 and 96hr 
differentiation in high calcium. Western blot analysis was performed using antibodies 
to Nbs1, Involucrin, and GADPH as a loading control. (C) DNA was harvested from 
human foreskin keratinocytes stably maintaining HPV31 genomes (HFK-31) at T0 or 
after 24 and 48hr differentiation in methylcellulose (MC), and analyzed by Southern 
blot analysis for amplification of viral genomes. DNA samples were digested with 
BamHI  (does not cut the viral genome, upper panel) or with HindIII to linearize viral 
genomes. The bar graph represents quantification of the episome copy number 
present at each time point, relative to T0 shScramble (set to 1). Densitometry was 
performed using ImageJ. (D) Western blot analysis was performed on lysates 
harvested from HFK-31 cells at T0 or after 24 and 48 hours differentiation in 
methylcellulose using antibodies to Nbs1 and Involucrin. GAPDH was used as a 
loading control. All results are representative of observations of four or more 
independent experiments. 
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Figure 2.7. Levels of cell cycle or replication proteins are not affected by Nbs1 
knockdown. Western blot analysis was performed on lysates harvested from 
CIN612 9E cells stably maintaining the scramble (shScram) or Nbs1 shRNAs at T0, 
or after 72 hours of differentiation in high calcium medium using antibodies to (A) 
Cyclin A, Cyclin E, and CDK2; (B) Cyclin B, CDC25C, and CDK1; and (C) RPA, as 
well as PCNA. GAPDH served as a loading control.  All results are representative 
observations of at least three independent experiments.   Ca=calcium. 
 
The MRN complex is disrupted upon Nbs1 knockdown. As Nbs1 functions 
in a complex with Mre11 and Rad50, we next wanted to determine if Nbs1 depletion 
affected the levels of Mre11 and Rad50.  As shown in Figures 5A and 8A, Nbs1 
knockdown had little effect on the levels of Mre11 or Rad50, as measured by 
Western blot analysis, consistent with previous studies (58).  Although Rad50 levels 
appear to decrease after 72 hours in high calcium (Figure 2.8A), this result was not 
consistently observed. Since Nbs1 contains a nuclear localization signal and is 
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necessary for the localization of Mre11 and Rad50 to the nucleus (52, 67), we next 
wanted to determine if Nbs1 depletion affected Mre11 and Rad50 localization.  As 
shown in Figure 2.8B, CIN612 9E cells exhibited increased levels of Mre11, Rad50 
and Nbs1 in the nucleus compared to uninfected HFKs, indicating increased MRN 
complex formation, which is consistent with our immunoprecipitation results (Figure 
2.4B).  However, upon depletion of Nbs1, we observed a dramatic decrease in levels 
of Mre11 and Rad50 in the nucleus of CIN612 9E cells and a marked re-localization 
to the cytoplasm (Figure 2.8C), indicating disruption of the MRN complex, as 
previously shown in NBS fibroblasts (40).  These results raise the possibility that 
formation of the MRN complex, rather than Nbs1 alone, is crucial to productive viral 
replication. To test this, we examined the effect of MIRIN, an inhibitor of Mre11 
nuclease activity, on productive replication of CIN612 9E cells. As shown in Figure 
2.8D, inhibition of Mre11 by MIRIN resulted in a decreased ability of viral episomes 
to amplify upon differentiation, similarly to Nbs1 depletion.  Similar results were 
observed in three independent experiments. Overall, these results indicate that the 
MRN complex is required for productive viral replication.  
56 
 
Figure 2.8. Nbs1 knockdown disrupts MRN complex formation. (A) Whole cell 
lysates were harvested from HFK, CIN612, and CIN612 9E cells stably expressing 
shScramble or shNbs1 at T0 and after 72hr differentiation in high calcium medium 
(Ca). Immunoblotting was performed using Mre11, Rad50 and Nbs1 antibodies. 
GAPDH was used as a loading control. (B) Total, nuclear (nuc), and cytoplasmic 
(cyto) lysates were harvested from HFK and CIN612 cells. Immunoblotting was 
performed using Mre11, Rad50 and Nbs1 antibodies. (C) Total, nuclear (nuc), and 
cytoplasmic (cyto) lysates were harvested from stable CIN612 9E shScramble and 
CIN612 9E shNbs1 cells. Immunoblotting was performed using Mre11, Rad50 and 
Nbs1 antibodies. For (B) and (C) Lamin A/C and tubulin were used to confirm 
nuclear and cytoplasmic fractionation, respectively. (D) DNA was harvested from 
CIN612 9E cells at T0 and after 72hr differentiation in high calcium medium with 
DMSO as a vehicle control or 50uM of the Mre11 inhibitor MIRIN. Southern blot 
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analysis was performed to analyze viral genome amplification of DNA digested with 
BamHI (non-viral genome cutter, upper panel) or HindIII (cuts viral genome once, 
lower panel).  All results are representative of observations of two or more 
independent experiments. 
 
Nbs1 knockdown affects the localization of Mre11, Rad50 and the HR 
factor Rad51 to HPV DNA foci. Since we previously observed that MRN 
components co-localize with HPV DNA foci(18), we next wanted to determine if 
Nbs1 knockdown affected the localization of Mre11 and Rad50 to sites of HPV DNA 
replication. We performed Fluorescence in Situ Hybridization (FISH) for HPV DNA 
coupled with immunofluorescence for Mre11 and Rad50, as described previously (3, 
18).  As shown in Figure 2.9, in undifferentiated CIN612 9E cells containing the 
scramble shRNA, we found Mre11 and Rad50 co-localized with viral genomes in 
~44%  5.6 and 41%  0.78 of cells containing HPV DNA foci, respectively (Figure 
2.9A-D). Upon differentiation in high calcium, this number significantly increased, 
with Mre11 and Rad50 co-localizing with viral genomes in 90  5.3% and 86  
0.98% of cells positive for HPV DNA foci, respectively. Consistent with viral genome 
amplification, the size of the Mre11/Rad50/HPV DNA foci increased upon 
differentiation.  In contrast, Nbs1 knockdown resulted in a significant decrease in the 
localization of Mre11 and Rad50 to HPV DNA foci in undifferentiated cells, with 
Mre11 and Rad50 localized to viral genomes in 9%  1.3 and 8%  4.3 of HPV DNA 
foci positive cells, respectively (Figure 2.9A-D). Although an increase in Mre11 and 
Rad50 localization to viral genomes was observed upon differentiation, this was 
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significantly less compared to the scramble control cells (Mre11 20%  17, Rad50 
14%  5.5). In addition, consistent with a block in viral genome amplification, the size 
of the HPV DNA/Mre11/Rad50 foci did not increase upon differentiation. These 
results suggest that Nbs1 may contribute to productive replication through the 
localization of MRN components to viral genomes. 
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Figure 2.9. Nbs1 knockdown results in decreased localization of Mre11, Rad50 
and Rad51 to viral genomes. Immunofluorescence (IF) for (A) Mre11 (red) and (B) 
Rad50 (red), followed by fluorescence in site hybridization (FISH) for HPV DNA 
(green) was performed on CIN612 9E cells stably maintaining the scramble or Nbs1 
shRNAs at T0 (undifferentiated), as well as after 72 hours differentiation in high 
calcium medium.  Cellular DNA was counterstained with DAPI.  (C, D) Bar graphs 
represents quantification of percent of HPV DNA foci positive cells that were also 
positive for (C) Mre11 and (D) Rad50. (E) Quantification of percent of cells positive 
for HPV DNA foci by FISH that were also positive for Rad51 by IF in CIN612 9E-
shScram and –shNbs1 cells at T0, as well as after 72 hours of differentiation in high 
calcium. The data represent the average of at least three independent experiments. 
The statistical analysis was assayed by 2-tailed t-test. Data=mean +/- standard 
error. ** = p-value less than 0.05. * = p-value less than 0.01. Ca=calcium. 
 
Since the MRN complex is important in facilitating ATM-mediated HR repair 
(22, 39), we examined the effect of Nbs1 knockdown on the localization of the 
principal HR factor Rad51, a recombinase we previously showed localized to HPV 
replication foci (18).  Interestingly, in undifferentiated cells, we found no difference in 
Rad51 localization to HPV DNA foci between the Scramble control (~41%  8.4) and 
Nbs1 knockdown (~44%  6.25) (Figure 2.9E).  Upon differentiation, however, while 
Rad51 localization to HPV DNA foci significantly increased in the Scramble control 
cells (~77%  3.4), no increase was observed in the Nbs1 knockdown cells, with 
Rad51 localizing to ~37%  12.8 of cells containing HPV DNA foci. Overall, these 
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results indicate that Nbs1 is required for the localization of Mre11 and Rad50 to viral 
genomes, and suggest that productively replicating genomes require Rad51 activity, 
which may rely on an intact MRN complex.  
 
Nbs1 knockdown moderately affects phosphorylation of ATM and Chk2 
in HPV positive cells. Nbs1, as part of the MRN complex, is an essential part of the 
DDR, acting upstream to activate ATM, as well as downstream in the intra-S phase 
checkpoint, and in the repair of DSBs through HR (13).  To determine if Nbs1 
contributes to productive viral replication through facilitating ATM activation, we 
examined the effect of Nbs1 depletion on ATM and Chk2 phosphorylation in CIN612 
9E cells.  We first examined the effect of stable Nbs1 knockdown on ATM pSer1981 
(pATM) and Chk2 pThr68 (pChk2) in undifferentiated cells over several passages.  
As shown in Figure 2.10, pATM and pChk2 were both decreased to a certain extent 
in response to Nbs1 depletion. While the decrease in pATM relative to total ATM 
ranged from 1.3-2-fold over the indicated passages, the decrease in Chk2 
phosphorylation relative to Chk2 was more dramatic, ranging from a 1.2 to 8.3-fold 
difference in this particular line (Figure 2.10). We previously showed that Chk2 
activation is dependent on ATM activity in HPV positive cells (12), indicating that a 
small decrease in ATM phosphorylation is sufficient to induce significant changes in 
downstream targets.  These results suggest that Nbs1 may affect viral genome 
amplification through its affects on ATM and Chk2, both of which are necessary for 
productive replication. 
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Figure 2.10. Phosphorylated ATM and Chk2 levels are decreased variably in 
response to Nbs1 knockdown. Whole cell lysates were harvested from stable 
CIN612 9E shScramble and shNbs1 cells at the indicated passages. Passage 22 
(p22) represents the passage at which the CIN612 9E cells were transduced with 
the respective shRNAs.  Each passage following transduction is represented by p22-
#. Lysates were immunoblotted with antibodies to phosphorylated ATM (Ser1981) 
(pATM) and Chk2 (Thr68) (pChk2), as well as total ATM, Chk2, and Nbs1. GAPDH 
served as a loading control. Protein levels were quantified using ImageJ, with 
phosphorylated protein levels first normalized to total levels and then GAPDH. Bar 
graphs represent the fold changes compared to the first passage of the shScramble 
cells for this representative experiment, which is set at 1. Results shown are 
representative of observations of three independent experiments. 
We next determined if Nbs1 knockdown results in a further decrease in pATM 
and pChk2 upon differentiation. As shown in Figure 2.11A and B, in this particular 
passage (p22-6) at time zero (undifferentiated), the levels of pATM in CIN612 9E-
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shNbs1 cells were decreased only 1.3-fold compared to scramble control, while 
pChk2 remained essentially unchanged. Upon differentiation, although Nbs1 levels 
decreased in CIN612-shNbs1 cells, there was no further decrease in pATM levels 
compared to total, and these cells exhibited only a moderate 1.6-fold decrease in 
pATM upon differentiation compared to scramble control.  Despite the relatively high 
level of pATM, however, viral genome amplification was still diminished in shNbs1 
cells (Figure 2.11C). Interestingly, the decrease in pATM levels in shNbs1 cells upon 
differentiation did not correlate with decreased pChk2 levels.  Rather, pChk2 levels 
increased relative to total Chk2 in CIN612-shNbs1 cells, as well as in CIN612-
shScramble and CIN612 control cells (Figure 2.11B). An increase in pChk2 was 
observed upon differentiation across multiple passages (Figure 2.12D), as well as 
with HFK-31-shScramble and –shNbs1 cells suspended in methylcellulose (data not 
shown).  While the decrease in pATM and pChk2 observed in undifferentiated cells 
suggests that Nbs1 contributes to their activation in HPV positive cells, the relatively 
high levels of pATM and pChk2 observed upon differentiation in shNbs1 cells 
potentially indicates an alternative mechanism for ATM activation, independent of 
the MRN complex. Overall, these data offer support that Nbs1 contributes to 
productive replication at least in part through a mechanism that is independent of 
promoting ATM activation. Nbs1 may serve as a downstream effector of ATM activity 
through phosphorylation, and/or ensure the localization of repair factors to viral 
genomes that are required for efficient DNA synthesis, which could potentially occur 
in a recombination-dependent manner.  
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Figure 2.11. Phosphorylation of ATM and Chk2 is maintained with Nbs1 
knockdown upon differentiation.  (A) Whole cell lysates were harvested from 
HFK, CIN612 9E, as well as CIN612 9E cells stably expressing shScramble or 
shNbs1 cells at T0 and 72hr after differentiation in high calcium medium. 
Immunoblotting was performed using antibodies to phosphorylated ATM (Ser1981) 
(pATM), total ATM and Nbs1. Tubulin was used as a loading control. Protein levels 
were quantified using ImageJ, with phosphorylated protein levels first normalized to 
total levels and then to tubulin. Levels for this representative experiment are graphed 
as fold change compared to the T0 HFK sample, which is set to 1. (B) Whole cell 
lysates were harvested from HFK, CIN612 9E, CIN612 9E shScramble, and CIN612 
9E shNbs1 cells at T0 and 72hr after differentiation in high calcium. Immunoblotting 
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was performed using antibodies to phosphorylated Chk2 (Thr68) (pChk2), total Chk2 
and Nbs1. GAPDH was used as a loading control. Protein levels were quantified 
using ImageJ as indicated above. Shown in a representative experiment where 
levels are graphed as fold change compared to the T0 HFK sample, which is set at 
1. (C) DNA was harvested from CIN612 9E, CIN612 9E shScramble, and CIN612 9E 
shNbs1 cells at T0 and after 72hr differentiation in high calcium, and linearized by 
digestion with HindIII.  HPV episomes were visualized via Southern blot analysis. 
Results shown are representative observations of four or more independent 
experiments. 
 
Levels of pATM and pChk2 do not influence productive viral replication. 
While we previously found that ATM and Chk2 activity is necessary for productive 
replication (12), it is unclear if higher levels of pATM and/or pChk2 could influence 
the ability of HPV to productively replicate. As shown in Figures 10 and 12B, in two 
independently derived CIN612-shScramble and shNbs1 lines, we have found that 
the levels of pATM and pChk2 fluctuate over time, with or without depletion of Nbs1. 
Similar results were observed for phosphorylated SMC1 S966 (pSMC1), a target of 
ATM that requires Nbs1 for phosphorylation and is involved in the intra-S phase 
checkpoint (Figure 2.12B) (68-70). To determine if the level of pATM and pChk2 in 
undifferentiated cells affects productive replication, and to further examine the effect 
of Nbs1 depletion on pATM and pChk2 levels upon differentiation, we examined viral 
genome amplification in three different passages of CIN612 9E cells stably 
expressing the scramble or Nbs1 shRNA (Figure 2.12C). We compared passages 
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19-2, 19-3 and 19-6, which in undifferentiated cells, Nbs1 knockdown resulted in a 
2.2-, 1.75- and 1.53- fold decrease in pATM, respectively, and a 1.4-, 2.2-, and 1.1- 
fold decrease in pChk2, respectively (Figure 2.12B). We found that even though the 
p19-6 Scramble control cells (undifferentiated) exhibited higher levels of pATM 
compared to p19-2 and p19-3 (Figure 2.12B), productive viral replication was not 
enhanced (Figure 2.12C).  Likewise, in the Nbs1shRNA cells, the higher level of 
pATM and pChk2 present in the p19-6 undifferentiated cells was not sufficient to 
allow for productive viral replication. In addition, as shown in Figure 2.12D, Nbs1 
knockdown had no significant affect on pATM and pChk2 levels upon differentiation 
when averaged across these three passages, and we observed similar results for 
pSMC1 (data not shown). The lack of productive replication in Nbs1 knockdown 
cells, despite maintenance of pATM and pChk2, furthers suggests that Nbs1 has a 
multifaceted role in promoting productive replication, one that is more complex than 
functioning solely to activate ATM.  
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Figure 2.12.  Levels of phosphorylated ATM and Chk2 do not influence viral 
genome amplification.  (A) DNA was harvested from CIN612 9E cells stably 
expressing shScramble and shNbs1 at the indicated passages, and digested with 
BamHI (non-viral genome cutter). HPV genomes were visualized via Southern blot 
analysis. Passage 19 (p19) represents the passage at which the CIN612 9E cells 
were transduced with the indicated shRNAs. P19-# indicates that passage at which 
DNA and protein were harvested following transduction. (B) Whole cell lysates were 
harvested from CIN612 9E shScramble and shNbs1 cells at the indicated passages, 
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and immunoblotting was performed with antibodies to phosphorylated ATM 
(Ser1981) (pATM), phosphorylated Chk2 (Thr68) (pChk2), phosphorylated SMC1 
(Ser966) (pSMC1) and total ATM, Chk2, SMC1 and Nbs1. GAPDH was used as a 
loading control. Protein levels were quantified using ImageJ, with phosphorylated 
protein levels first normalized to total levels and then GAPDH. Levels are graphed 
as fold change compared to the first passage (p19-2) of the shScramble cells, which 
is set to 1. (C) DNA was harvested from p19-2, p19-3 and p19-6 CIN612 9E 
shScramble and shNbs1 cells at T0 and after differentiation for 72hr in high calcium 
medium. Southern blot analysis was performed to analyze viral genome 
amplification. Levels of HPV episomes were quantified using Image J; episome 
amounts are shown relative to the T0 shScramble, which is set to 1. (D) Protein was 
harvested from p19-2, p19-3 and p19-6 CIN612 9E shScramble and shNbs1 cells at 
T0 as well as after 72hr differentiation in high calcium medium.  Western blot 
analysis was performed using antibodies to phosphorylated ATM (S1981) (pATM), 
and phosphorylated Chk2 (Thr68) (pChk2). GAPDH served as a loading control. 
Protein levels were quantified using ImageJ, as described above.  Graphed is the 
average fold change in pATM and pChk2 levels across the three passages in 
undifferentiated shScram and shNbs1 cells compared to cells differentiated in high 
calcium for 72hr.  Fold change is shown relative to shScram T0, which is set to 1. 
Results shown are representative of observations of three or more independent 
experiments. 
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DISCUSSION 
Previously, we demonstrated that MRN components localize to sites of HPV 
DNA synthesis (18). We have now found that Nbs1 is necessary for productive 
replication, though exactly how Nbs1 contributes to efficient viral DNA synthesis is 
unclear.  Nbs1, as part of the MRN complex, acts as a sensor of DNA breaks and 
also regulates activation of ATM (32, 39). We have found that depletion of Nbs1 
disrupts formation of the MRN complex, resulting in re-localization of Mre11 and 
Rad50 to the cytoplasm. This, coupled with the finding that the nuclease activity of 
Mre11 is also required for productive replication, suggests a key role for the MRN 
complex during the productive phase of the viral life cycle.  
One of the simplest explanations for how Nbs1 contributes to productive viral 
replication is through facilitating activation of ATM. However, while Nbs1 knockdown 
did affect the levels of pATM and pChk2 to some extent, pATM and pChk2 remained 
quite high for most passages, especially upon differentiation.  Despite the presence 
of pATM and pChk2, however, a defect in HPV genome amplification was 
consistently observed.  These results suggest that Nbs1, while certainly influencing 
activation of ATM in HPV-infected cells, is likely playing a role outside of its function 
as an upstream regulator of ATM activation to drive productive viral replication.   
There are several possible ways by which Nbs1 could contribute to viral 
replication independently of activating ATM.  Nbs1 is a target for phosphorylation by 
ATM on Ser343, and this phosphorylation is necessary for activation of the intra-S 
phase checkpoint (71), which serves to slow down cellular DNA replication in 
response to DNA damage (70). However, while phosphorylation of SMC1, a key 
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regulator in this checkpoint (68, 69), was decreased upon Nbs1 knockdown, pSMC1 
levels exhibited little change upon differentiation, suggesting that a block in the intra-
S phase checkpoint was not responsible for the abrogation of productive replication. 
Nbs1 has also been implicated in DNA damage-induced apoptosis (72). While we 
have shown that caspase activation is necessary for productive viral replication (66), 
Nbs1 knockdown had no effect on caspase activation in differentiating cells (data not 
shown). This is not surprising, as pChk2 levels were not affected upon differentiation 
by Nbs1 depletion, and we previously found Chk2 activation to be necessary for 
caspase activation (66).  
As mentioned, downstream of ATM activation, Nbs1 and the MRN complex 
also assist in the repair of DNA breaks, primarily through homologous recombination 
(HR) when cells are in S or G2 phases of the cell cycle (32). Nbs1, as part of this 
complex, has specific functions that contribute to efficient HR repair. Nbs1 contains 
protein-protein interaction motifs important for the localization of MRN to nuclear foci 
(52, 73, 74), as well as the recruitment of CtIP (CtBP-interacting protein) to DNA 
DSB ends for end processing and HR (22, 75-77).  In addition to two ATM 
phosphorylation sites (S278, S343) (71, 78, 79), Nbs1 is also phosphorylated by 
CDK2 on Ser432, which stimulates MRN-dependent conversion of DSBs into 
structures recognized by HR for repair (80, 81). Furthermore, recent studies indicate 
that Nbs1 may be required for Rad51 localization to RPA-coated DNA, and the 
restart of stalled replication forks (81, 82).  
Our finding that productive viral replication requires ATM activity and Nbs1, 
coupled with the localization of the MRN complex and the HR factors Rad51 and 
70 
Brca1 to sites of viral genome synthesis (18, 83), suggests that recombination-
dependent repair may play a role in productive viral replication. We have found that 
Mre11, Rad50 and Rad51 increase in localization to viral genomes upon 
differentiation, and that this is abrogated in the absence of Nbs1. These results 
suggest that these repair and recombination factors are required at viral DNA to 
ensure efficient productive replication, possibly through facilitating HR.  In support of 
this, preliminary studies from our lab indicate that Rad51 is necessary for productive 
viral replication (W. Chappell and C. Moody, unpublished). Whether Nbs1 recruits 
Rad51 to viral DNA, or if productive replication results in HR structures that are 
processed by MRN then bound by Rad51, is currently unclear. The massive 
amplification of HPV genomes upon differentiation could result in DSBs or stalled 
replication forks that require ATM-mediated HR to re-start (84), and it will be 
important to examine the effect of ATM inhibition, as well as depletion of Nbs1 on 
the formation of replication intermediates to assess this possibility, as has been 
done recently for SV40 (85).   
Curiously, we found that Mre11 and Rad50 localize to viral genomes in ~40% 
of cells containing HPV DNA foci in undifferentiated Scramble control cells, despite 
Nbs1 not being required for episomal maintenance. The possibility exists that the 
MRN complex contributes to viral replication in undifferentiated cells, but in its 
absence, replication proceeds efficiently enough such that episomal copy number 
and maintenance are not affected at a discernable level.  This may also apply to 
Rad51, which we also found localized to viral genomes in a similar percentage of 
undifferentiated HPV DNA foci positive cells. In contrast to Mre11 and Rad50 
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though, Nbs1 depletion did not affect Rad51 localization to viral genomes in 
undifferentiated cells. However, recent studies have shown that in the absence of 
Nbs1, Rad51 foci can serve as markers of HR substrates, such as replication 
intermediates, rather than serve as an indicator of HR activity (86). Understanding 
the contribution of Rad51 and recombination to maintenance replication, in addition 
to productive replication, will be important areas of future research. 
The finding that ATM and Chk2 are phosphorylated at high levels in 
differentiating cells upon Nbs1 knockdown suggests that either ATM activation 
occurs in an MRN-independent manner, or that an alternative mode of ATM 
activation is stimulated in the presence of decreased Nbs1. The ATM interactor 
(ATMIN) protein is required for ATM signaling in an Nbs1-independent manner in 
response to hypotonic stress, as well as inhibitors of replication such as hydroxyurea 
(87). Nbs1 knockdown could potentially increase the flux through the ATMIN-
dependent arm of the ATM signaling pathway (87, 88), maintaining phosphorylation 
of ATM targets. The DNA repair protein 53BP1, which is expressed at high levels in 
HPV positive cells (18), has also been shown to be a mediator of ATM function (89, 
90), with its effects on ATM activity enhanced in situations in which the MRN 
complex is present at low levels (90). Activated STAT5 has been shown to be 
necessary for ATM activation in HPV-positive cells (16), though whether this occurs 
in an MRN-dependent manner is unclear. Regardless, the maintenance of ATM 
signaling upon differentiation is not sufficient to drive productive viral replication, as 
the decreased levels of Nbs1 still act as a barrier to viral replication. Understanding 
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the role of the MRN complex in the regulation of ATM activity in HPV-infected cells 
will be the focus of future investigations. 
Our studies indicate that E7 expression is sufficient to increase protein levels 
of MRN components, as well as that of other repair factors, such as Chk2. 
Interestingly, E7 significantly increased only the transcript levels of Mre11, which 
may in turn serve to stabilize protein levels of Nbs1 and Rad50 in infected cells. We 
previously showed that HPV positive cells exhibit increased levels of key proteins 
involved in HR repair (18), including Rad51 and Brca1, and preliminary studies 
indicate this occurs in an E7- and E2F-dependent manner (W. Chappell, B. Johnson, 
and C. Moody, unpublished). Taken together, these results suggest that E7 may 
increase levels of proteins involved in the DNA damage response to support viral 
replication. Recent studies by Hong and Laimins demonstrated the protein levels of 
ATM, Chk2, Brca1 and Rad51 decreased upon STAT5 depletion (16). Deregulation 
of E2F and STAT5 activity may be necessary to ensure sufficient levels of DNA 
repair genes that drive viral replication in response to E7-, or potentially E6- and E1-
induced DNA damage (8, 15, 17, 83).  
We have found that E7 immunoprecipitates with Nbs1, but in a manner 
independent of ATM. Interestingly, we found that E7 also immunoprecipitates with 
Rad50, but not Mre11. Nbs1 has been shown to be capable of forming a complex 
with Rad50 (91), and it will be important to determine if E7 binds directly with either 
of these MRN components, as has been shown for HSV UL12 (44). We have found 
that immunoprecipitation of Mre11 does not pull down E7 (data not shown), 
suggesting that at least two, possibly three, complexes exist in HPV-infected cells: 
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Mre11/Rad50/Nbs1 and E7/Nbs1/+/-Rad50. E7 may form a complex with Nbs1 in 
the nucleus, regulating its stability when not bound to Mre11. Several studies 
indicate the activity of Nbs1 is regulated by post-translational modifications, including 
acetylation in addition to phosphorylation, and E7 may contribute to this regulation 
through multiple mechanisms. E7 increases levels of SIRT1 (93), which deacetylates 
Nbs1 to allow its phosphorylation by ATM on S343 (92). E7 decreases the 
acetyltransferase activity of PCAF (94), which has been shown to acetylate Nbs1 
and block phosphorylation (92). In addition, E7 maintains CDK2 activity (5, 95, 96), 
and may target Nbs1 for phosphorylation through binding, potentially regulating HR 
repair in HPV infected cells.  
In summary, our studies demonstrate that HPV utilizes Nbs1 and the MRN 
complex for efficient productive replication. Nbs1 knockdown does not significantly 
affect the phosphorylation of ATM and Chk2 upon differentiation, suggesting that 
Nbs1 may contribute to efficient productive replication outside of its ability to 
facilitate ATM activation, potentially through the localization of Mre11, Rad50 and 
Rad51 to viral genomes. In addition, we have shown that E7 affects expression of 
DNA repair factors that are required for productive replication. E7 may further 
modulate the DNA damage response and drive viral replication through interactions 
with components of the MRN complex.  
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CHAPTER 3: HPV31 UTILIZES THE ATR-CHK1 PATHWAY TO MAINTAIN 
ELEVATED  RRM2 LEVELS AND A REPLICATION-COMPETENT 
ENVIRONMENT IN DIFFERENTIATING KERATINOCYTES 
 
OVERVIEW 
The life cycle of human papillomaviruses (HPV) is intimately linked to the 
differentiation status of the host cell, with productive viral replication and virion 
formation restricted to the uppermost layers of the stratified epithelium. While cell 
cycle re-entry upon differentiation provides an environment conducive to rapid 
amplification of viral genomes, the mechanisms by which HPV ensures an adequate 
supply of cellular substrates for viral DNA synthesis are unclear. RRM2 is a key 
component of the ribonucleotide reductase (RNR) complex, which is required for de 
novo synthesis of dNTPs, the building blocks of nucleic acid.  In this study, we have 
found that HPV31 positive cells exhibit increased RRM2 levels accompanied by 
elevated dNTP pools. RRM2 expression is regulated in an E2F1-dependent manner, 
and expression of E7 is sufficient to increase RRM2 at the transcript and protein 
level. Loss of RRM2 expression blocks productive replication, suggesting that HPV 
requires increased RRM2 to provide dNTPs for accelerated viral DNA synthesis in 
differentiating cells. Interestingly, we have found that RRM2 levels are regulated in 
HPV31 positive cells by activation of the ATR-Chk1-E2F1 DNA damage response 
pathway, which is essential to combat replication stress upon entry into S-phase.
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Importantly, ATR and Chk1 have recently been shown to be required for productive 
HPV31 replication. Overall, our studies suggest that E7-induced cycle re-entry upon 
differentiation triggers replication stress that activates ATR and Chk1. In turn, 
increased levels of E2F1 drive RRM2 expression to facilitate productive viral 
replication. 
INTRODUCTION 
Human papillomaviruses (HPV) are small, double stranded DNA viruses that 
exhibit a strict tropism for epithelial cells. A subset of approximately 15 HPVs, 
termed high-risk (HR) (e.g. HPV16, 18, 31, 45), is the causative agent of cervical 
cancer, and is also associated with other genital malignancies, as well as an 
increasing number of head and neck cancers (1). While the three licensed HPV 
vaccines show great efficacy and offer great promise in reducing the number of 
deaths due to cervical cancer, these vaccines are not therapeutic. Identifying cellular 
pathways HPV commandeers to promote replication may identify potential 
therapeutic targets to limit viral replication and block disease progression.  
The limited coding capacity of the HPV genome renders the virus reliant on 
cellular factors for viral replication. The viral life cycle is intimately linked to the 
differentiation status of the stratified epithelium and is characterized by three distinct 
phases of replication (2). HPV infects the actively dividing basal cells of the stratified 
epithelium, where viral episomes undergo limited amplification to 50-100 copies per 
cell. Viral genomes are then maintained in these undifferentiated cells by replicating 
once per cell cycle along with cellular DNA.  Upon epithelial differentiation, the 
productive phase of the viral life cycle is triggered, resulting in amplification of viral 
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genomes to 1000s of copies per cell, late gene expression and virion production. 
Paradoxically, these late viral events occur in cells that normally would have exited 
the cell cycle. HPV circumvents this problem largely through E7’s ability to target the 
tumor suppressor Rb for degradation, resulting in the release of active E2F 
transcription factors that drive expression of genes required for entry into the cell 
cycle (3). Traditionally, cell cycle re-entry has been thought to provide an S phase 
environment conducive to rapid amplification of viral genomes. However, more 
recent studies indicate that productive replication occurs post-cellular DNA 
synthesis, in a prolonged G2-like phase (4). Therefore, HPV must have evolved 
means to provide cellular factors required for productive replication outside of S 
phase.  
One of the most important resources HPV needs to acquire for productive 
replication is a sufficient supply of deoxyribonucleotide triphosphates (dNTPs), the 
building blocks for DNA synthesis. However, it is unclear how dNTP pools are 
maintained in a differentiating environment where infected cells are no longer 
dividing. The ribonucleotide reductase (RNR) enzyme complex is required for de 
novo synthesis of dNTPs (5).  RNR is the rate-limiting enzyme for dNTP synthesis, 
catalyzing the conversion of ribonucleoside diphosphates to their corresponding 
deoxyribonucleoside diphosphates (dNDP). Subsequent phosphorylation of dNDPs 
by the nucleoside diphosphate kinase provides balanced pools of dNTPs utilized for 
DNA replication, as well as repair. The active form of RNR is a tetramer composed 
of two identical large subunits of RMM1, and either two identical small subunits of 
RRM2, or an alternative subunit p53R2, which is p53-responsive (5, 6). In 
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proliferating cells, the RRM1-RRM2 holoenzyme provides dNTPs for replication and 
repair in S phase, while RRM1-p53R2 is active in G0/G1 where the consumption of 
dNTPs is minimal and restricted to mitochondrial DNA replication and repair.   
RNR activity is tightly regulated in a cell-cycle dependent manner through 
multiple mechanisms to coordinate the balance between dNTP synthesis and DNA 
replication. While levels of RRM1 remain constant throughout the cell cycle, RRM2 
levels fluctuate, reaching their highest level in S-phase (7-9). The fluctuation in 
RRM2 is attributed to transcriptional regulation via the E2F1 transcription factor (10, 
11), as well as proteasome-mediated degradation by the anaphase promoting 
complex/Cdh1 in G1 (12), and by SCFcyclinF in G2 (13). The S-phase specific 
elevation in RRM2 coincides with a significant increase in RNR activity (9, 14, 15). 
Thus, RRM2 is considered limiting for RNR activity. Indeed, loss of RRM2 
expression results in decreased dNTP levels (16, 17). RNR activity is important to 
genomic integrity, as well as cell viability, with an increase or imbalance of dNTP 
pools leading to mutagenesis (18), and decreased dNTP levels leading to impaired 
DNA replication and repair (5). Previous studies demonstrated that RRM2 transcript 
and protein levels are increased in cervical cancer lines containing chromosomally 
integrated HPV16 and HPV18 genomes (19). HPV16 E7 was found to be sufficient 
to increase RRM2 transcript levels in a manner dependent on E7’s interaction with 
Rb. However, whether RRM2 is increased in lines containing episomal HPV 
genomes and is important for viral replication has not been examined.  
Recent studies have shown that levels of RRM2 can also be regulated 
through activation of the DNA damage kinase ATR (Ataxia telangiectasia and Rad3-
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related) and its downstream effector kinase Chk1 (13, 20-22). The importance of the 
DNA damage response (DDR) to HPV replication is becoming increasingly clear 
(23). Previous studies identified a role for the DDR kinase ATM (Ataxia 
Telangiectasia-Mutated) in productive replication of HPV31 (24), which may facilitate 
viral DNA synthesis, at least in part, through the recruitment of DNA repair factors to 
viral replication centers (25, 26). While ATM responds primarily to double-strand 
DNA breaks, ATR is activated by single-strand DNA generated by DNA damage, as 
well as by stalled replication forks upon replication stress (27, 28). ATR 
phosphorylates and activates Chk1, which is then released from chromatin to 
phosphorylate targets throughout the nucleus (29). Activation of ATR and Chk1 is 
critical for stabilization of stalled replication forks, and numerous studies suggest that 
the ATR-Chk1 pathway is essential for cancer cell survival in the face of replication 
stress (30-32). Recent studies by Bertoli et al demonstrated that the G1/S 
transcriptional program is rewired in response to replication stress in a Chk1-
dependent manner, leading to high-level expression of genes involved in DNA 
repair, as well as nucleotide synthesis, including RRM2 (20). In addition, several 
studies have demonstrated that the ATR-Chk1 pathway promotes RRM2 
accumulation through stabilization of E2F1, in turn providing dTNPs to prevent DNA 
damage and cell death (20, 22, 30).  
HR HPVs are known to induce replication stress through expression of the E6 
and E7 oncogenes (33, 34). E6/E7 expression drives uncontrolled S-phase entry, 
resulting in a disconnect between replication and supplies required for replication, 
ultimately leading to DNA damage.  Several studies have shown that the ATR-Chk1 
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pathway is active in HR HPV positive cells (24, 35-37), indicating that replication 
stress also occurs in the context of a viral infection. ATR-Chk1 activation can be 
induced independently by E7 (35), as well as the viral helicase E1 (36, 37), and 
inhibition of Chk1 activity decreases the stability of HPV genomes in undifferentiated 
cells (38). In addition, the ATR-Chk1 pathway has recently been shown to be 
required for productive replication of HPV31 (35), though how ATR and Chk1 activity 
contributes to viral replication was not examined. The activation of ATR and Chk1 in 
both undifferentiated and differentiating HPV positive cells suggests that replication 
stress occurs throughout the viral life cycle. Activation of the ATR/Chk1 pathway 
through HPV-induced replication stress may be required to maintain an environment 
conducive to the rapid amplification of viral genomes upon differentiation through 
stabilization of E2F1 and subsequent elevation of RRM2.  
In this study, we demonstrate that high-risk HPV positive cells exhibit specific 
elevation of RRM2 levels, with little to no effect on the large subunit RRM1, or the 
alternative subunit p53R2. We have found that the increase in RRM2 corresponds 
with HPV31 positive episomal lines exhibiting higher levels of dNTPs compared to 
uninfected cells, which importantly, are maintained upon differentiation. Loss of 
RRM2 expression results in a decrease in viral copy number in undifferentiated cells 
and a block in productive replication upon differentiation. We have found the levels 
of RRM2 in HPV31 positive cells are regulated through the ATR-Chk1 DNA damage 
pathway through maintenance of the E2F1 transcription factor. Overall, our studies 
suggest that HPV exploits the ATR-Chk1 axis of the DDR to induce E2F1 and RRM2 
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accumulation upon differentiation, providing a replication-competent environment for 
completion of the viral life cycle.  
 
MATERIALS AND METHODS 
Cell Culture Human foreskin keratinocytes (HFKs) were collected from 
neonatal foreskin tissue as described previously (39) and were maintained in 
Dermalife keratinocyte growth media (KGM; Lifeline). HPV31 positive CIN612 9E 
cells were grown in E-media supplemented with 5ng/mL mouse epidermal growth 
factor (BD Biosciences) and co-cultured mitomycin C treated J2 3T3 fibroblasts, as 
described previously (40). Generation and maintenance of HFKs retrovirally 
transduced with pLXSN-HPV31 E6, pLXSN-31 E7, and pLXSN-31 E6/E7 in 
combination has been previously described (41). Prior to harvesting DNA, protein or 
RNA, fibroblast feeder cells were removed from HPV positive cells using Versene (1 
mM EDTA in phosphate-buffered saline). 293T cells were grown Dulbecco’s 
modiﬁed Eagle’s medium (DMEM; Life Technologies) supplemented with 10% 
bovine growth serum (BGS; ThermoFisher Scientiﬁc).  
 
Plasmids and Inhibitors The pLXSN-HPV31 E6, -HPV31 E7, and -HPV31 
E6/E7 vectors have been previously described (42). The pBR322 plasmid containing 
the wild-type HPV31 genome was previously described (42, 43). The p1203 PML2d 
HPV16 plasmid containing the wild-type HPV16 genome was obtained from 
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Addgene (plasmid no. 10869). VE-821 was obtained from Selekchem, and UCN-01 
was obtained from EMD Millipore. 
 
Generation of HPV16- and HPV31-Positive HFKs HFKs stably maintaining 
HPV16 or HPV31 episomes were created as previously described (40). Briefly, 
HPV16 and HPV31 genomes were excised from the plasmid backbones using 
BamH1 and HindIII, respectively (New England Biolabs) and re-ligated using T4 
DNA ligase (Life Technologies). Primary HFKs were transfected with 1ug of the re-
ligated genomes and 1ug PSV2-Neo using Fugene 6 according to manufactures 
instructions (Promega). Stable cell lines were generated through eight days of G418 
selection (Sigma), and surviving populations were pooled and expanded for 
analysis. 
 
Induction of Keratinocyte Differentiation High calcium medium was used 
to induce epithelial differentiation as previously described (44). Sub-conﬂuent cells 
were harvested as T0, and the remaining plates of cells were serum starved in basal 
keratinocyte growth medium (KGM; Lonza) with supplements for 16 h. Cells were 
then incubated in keratinocyte basal medium (KBM; Lonza) without supplements but 
with 1.8 mM CaCl2 (Sigma). Cells were allowed to differentiate for 24, 48, 72, or 96 h 
after addition of high calcium medium. DNA, RNA and protein were harvested at 
each time point, and viral genome ampliﬁcation was measured by Southern blotting 
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for each experiment to ensure activation of the productive phase of the viral life 
cycle. 
 
Production of Lentivirus Lentivirus was produced as previously described 
(45). Plasmids encoding shRNAs for RRM2 (TRCN0000038962 and 
TRCN0000038963) were obtained from the UNC Lentiviral Core (UNC-Chapel Hill), 
and a scramble non-target control shRNA in the pLKO background was obtained 
from Open Biosystems. Each shRNA plasmid (5ug) was co-transfected with 3.37ug 
Gag-Pol-Tet-Rev plasmid DNA and 1.66ug vesicular stomatitis virus G (VSV-G) 
plasmid DNA into 293T cells using polyethylenimine (PEI) to generate lentivirus 
particles. Supernatants containing lentivirus were harvested 72 h post-transfection, 
sterile ﬁltered, and stored at -80°C until used. CIN612 9E cells were transduced with 
5mL viral supernatant plus 4.8ug/mL hexadimethrine bromide (polybrene; Sigma-
Aldrich) for three days prior to harvesting or differentiation in high calcium medium.  
 
Western Blot Analysis Whole cell lysates were harvested in 
radioimmunoprecipitation assay (RIPA) lysis buffer supplemented with Complete 
Mini and PhosSTOP tablets (Roche). Total protein levels were determined via Bio-
Rad protein assay. Equal protein amounts were electrophoresed on SDS-
polyacrylamide gels and transferred to polyvinylidene difluoride (PVDF) membranes 
(Immobilon-P; Millipore). The following primary antibodies were used: RRM2, RRM1, 
p53R2, GAPDH, Involucrin (Santa Cruz); Chk1 (Abcam); phospho-Chk1 Ser345, 
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E2F1 (Cell Signaling Technologies). Secondary antibodies used were: HRP 
conjugated anti-goat (Santa Cruz), HRP conjugated anti-rabbit (Cell Signaling 
Technologies), and HRP conjugated anti-mouse (GE Life Sciences). Clarity Western 
enhanced chemiluminescence (ECL) blotting substrate (Bio-Rad) was used to detect 
antibody binding. 
 
Southern Blot Analysis DNA isolation and Southern blotting were performed 
as previously described (46). Briefly, cells were harvested in DNA lysis buffer 
consisting of 400mM NaCl, 10mM Tis pH 7.5 and 10mM EDTA. Cells were lysed by 
the addition of 30uL 20% SDS and subsequently treated with 15ul of 10mg/mL 
proteinase K overnight at 37˚C. DNA was extracted by phenol chloroform extraction, 
followed by ethanol precipitation in the presence of sodium acetate. DNA was then 
digested with BamHI (New England Biolabs) (which does not cut the genome), or 
HindIII (New England Biolabs) (which cuts the genome once). DNAs were resolved 
on a 0.8% agarose gel for 15 h at 40 V, and transferred to a positively charged nylon 
membrane (Immobilon-Ny+; EMD Millipore). The DNA was fixed to the membrane 
via UV irradiation and then hybridized to a radioactive DNA probe consisting of 32P-
labeled linearized HPV31 genome. 
 
Measurement of Intracellular dNTPs HFK, HFK-31 and CIN612 cells were 
seeded in duplicate for each time point at 5 x 105 in 10cm dishes. 72hr following 
seeding, cells were either harvested as a undifferentiated sample (T0) for dNTP 
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analysis or exposed to high calcium medium for 72hr to induce differentiation. At the 
indicated time points, cells were lysed in ice cold 65% methanol, and vigorously 
vortexed for two minutes. Extracts were then incubated at 95 °C for three minutes, 
chilled for one minute on ice, then centrifuged for three minutes at 14,000 RPM. 
Supernatants were collected and dried in a speed vacuum. Samples were 
processed for the HIV-1 reverse transcriptase-based single nucleotide incorporation 
assay as previously described (47). 
 
Measurement of Ribonucleotide Synthesis Ribonucleotide synthesis was 
measured as previously described (48). Briefly, HFK and CIN612 cells were seeded 
in triplicate at 3 x 105 cells/well, and 1.5 x 105 cells/well in 6 well plates, respectively. 
Cells were cultured in E-media in the presence of mitomycin C-treated J2 3T3 
fibroblasts. Forty-eight hours post-seeding, cells (undifferentiated sample, T0) were 
labeled with 5.0 μCi/mL D -(U-14C)-glucose in serum-free DMEM containing 200 μM 
glucose, without pyruvate, for two hours at 37°C. Cells were similarly labeled at 72 
hours post-differentiation in high calcium medium. Total RNA was harvested from a 
separate sample in RNA STAT-60 and extracted according to the manufacturer’s 
instructions (Tel-Test). 14C incorporation was measured by scintillation counting in 
Ecoscint fluid (National Diagnostics) on a PerkinElmer Tri-Carb 2810 TR. The level 
of 14C incorporation was normalized to total RNA present in the unlabeled control 
sample. 
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Quantitative Reverse Transcription PCR (RT-PCR) Total RNA was isolated 
from HFKs, HFKs stably expressing HPV31 E6, E7, or E6/E7, as well as CIN612 
cells using RNA STAT 60 (Tel-Test), followed by the removal of contaminating DNA 
via treatment with RQ1 DNAse 1 according to manufacturer instructions (Promega). 
One microgram of RNA was reverse transcribed using iScript reverse transcription 
kit (Biorad). Fifty nanograms of cDNA was then analyzed in triplicate reactions using 
quantitative PCR with 375 nM primers and iTaq Universal SYBR Green Supermix 
(Biorad) in a total reaction volume of 10ul. Reactions were carried out on an ABI 
QuantStudio 6 Flex thermal cycler with a thermal profile of 10 min denaturation at 
95°C, followed by 40 cycles of 95°C for 15 sec, 60°C for 30 sec, then 72°C for 30 
sec. Data was analyzed using version 1.0 of the QuantStudio 6 and 7 Flex software. 
The gene-specific primer sequences utilized were as follows: RRM2 (Forward 5’-
CTGGCTCAAGAAACGAGGACTG-3’; Reverse 5’-
CTCTCCTCCGATGGTTTGTGTAC-3’), RRM1 (Forward 5’-
AAAGGAAGAGCAGCGTGCCAGA-3’; Reverse 5’-
ACCTCATCCAGACCAGGACAC-3’), E2F1 (Forward 5’-
ATGTTTTCCTGTGCCCTGAG-3’; Reverse 5’-ATCTGTGGTGAGGGATGAGG-3’), 
GAPDH (Forward 3’- CTGTTGCTGTAGCCAAATTCGT -5’; Reverse 3’- 
ACCCACTCCACCTTTGAC -5’). Relative transcript amounts were calculated using 
2-ΔΔCT with GAPDH as the reference gene and normalized to uninfected HFK or 
pLXSN-vector control samples.   
 
95 
RESULTS 
RRM2 levels are increased in HPV episomal lines. Previous studies 
demonstrated that RRM2 protein levels are increased in cervical cancer cells 
containing integrated viral genomes (19).  To determine if RRM2 levels are also 
increased in lines harboring episomal copies of HPV, we compared the level of 
RRM2 protein in uninfected human foreskin keratinocytes (HFKs) to HPV31 positive 
CIN162 cells, which are derived from a CIN1 cervical lesion. We also examined 
RRM2 protein levels in HPV positive lines generated in the laboratory through 
transfection of HFKs with HPV31 (HFK-31) and HPV16 (HFK-16) genomes, followed 
by selection in neomycin. As shown in Figure 3.1A, RRM2 protein levels were 
substantially higher in CIN612 cells, as well as HFK-31 and HFK-16 cells compared 
to uninfected HFKs.  In contrast, levels of RRM1, as well as the alternative R2 
subunit p53R2 were similar between the HFKs and HPV positive lines. To determine 
if elevated levels of RRM2 were maintained during the productive phase of the viral 
life cycle, we induced differentiation through growth in high calcium medium, which 
is commonly used to activate the productive phase of the viral life cycle. As shown in 
Figure 3.1B, we found that RRM2 levels remained elevated in CIN612 cells upon 
differentiation compared to uninfected HFKs, which in contrast, sharply declined. 
Interestingly, while RRM1 levels were again maintained at similar between HFKs 
and CIN612 cells upon differentiation, p53R2 levels consistently decreased in 
CIN612 cells (Figure 3.1B). These results suggest that HPV specifically elevates 
levels of the RRM2 RNR subunit.  
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Figure 3.1. RRM2 protein and transcript levels are increased in HPV positive 
cells. (A) Whole cell lysates harvested from undifferentiated human foreskin 
keratinocytes (HFKs), HFKs stably maintaining HPV16 (HFK-16) or HPV31 (HFK-
31) genomes, and HPV31 positive CIN612 cells were immunoblotted with antibodies 
to RRM2, RRM1, and p53R2. GAPDH served as a loading control. (B) Whole cell 
lysates were harvested from undifferentiated (T0) HFKs and CIN612 cells, as well as 
after differentiation in high calcium medium for 48 and 96hr. Immunoblotting was 
performed using antibodies to RRM2, RRM1, and p53R2, with GAPDH serving as a 
loading control. Ca=Calcium. (C) RNA was extracted from HFKs and CIN612 cells 
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prior to (T0) and post-differentiation for 48 and 96hr in high calcium medium. 
Quantitative RT PCR was performed using RRM2-specific primers. Expression 
levels were calculated using GAPDH as the reference gene and are shown relative 
to the uninfected HFKs (T0), which is set at 1. Fold change was calculated using the 
2-ΔΔCT method. Values represent averages from three independent experiments +/- 
standard error of the means. *p≤ .05, **p≤ .01. 
Since RRM2 levels are regulated in part at the level of transcription, we next 
wanted to determine if the increased RRM2 protein levels in HPV positive cells 
correlated with increased mRNA levels. As shown in Figure 3.1C, similar to the 
results observed by Western blot analysis, RRM2 transcript levels were significantly 
increased in CIN612 cells relative to HFKs prior to differentiation, as well as upon 
differentiation in high calcium medium. In contrast, RRM2 message levels decreased 
in HFKs upon differentiation (Figure 3.1C). These results suggest that HPV31 
increases RRM2 protein, at least in part, at the level of transcription.  
 
dNTP pools are elevated in HPV31-positive cells throughout the viral life 
cycle. Levels of RRM2 are thought to regulate the activity of the RNR complex, with 
higher RRM2 correlating with increased reduction of ribonucleotides to 
deoxyribonucleotides (dNTPs) (5). To determine if the increased RRM2 levels 
observed in HPV31 positive cells coincided with elevated nucleotides, we measured 
dNTP pools in HFKs, CIN612 cells, as well as HFK-31 cells.  As shown in Figure 
3.2A, intracellular pools of dATP, dCTP and dTTP were all markedly increased in 
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undifferentiated CIN612 cells, as well as HFK-31 cells compared to the matched 
uninfected HFKs. dGTP levels were also increased, but to a lesser extent. 
Furthermore, all four dNTP pools were maintained at elevated levels in HPV31 
positive cells upon differentiation in high calcium medium (Figure 3.2A). In contrast, 
dNTP pools were reduced to undetectable levels in HFKs upon differentiation 
(Figure 3.2A), mirroring the rapid decline in RRM2 protein levels (Figure 3.1B). 
These results suggest that HPV increases dNTP pools through elevated RRM2 
levels and RNR activity.  
 
99 
Figure 3.2. HPV31 positive cells exhibit elevated dNTP levels throughout the 
viral life cycle. (A) Individual dNTP pools were measured in HFKs, HFK-31 cells, as 
well as CIN612 cells prior to differentiation (T0) and after 72hr differentiation in high 
calcium medium using a HIV-1 reverse transcriptase-based dTNP assay. Values 
represent the averages of three separate experiments +/- standard error of the mean. 
*p≤ .05, **p≤ .01. (B) Total nucleotide synthesis was examined in undifferentiated (T0), 
as well as differentiated (72hr in high calcium medium) HFK and CIN612 cells by 
measuring the incorporation of D-(U-14C)-glucose into RNA. Total RNA was extracted 
and 14C incorporation was determined by measuring counts per minute using a 
scintillation counter. Counts per minute were then normalized to total RNA for each 
sample. Values represent the averages of three separate experiments +/- standard 
error of the mean. Ca=calcium. 
 
We next wanted to determine if the increased dNTP pools observed in HPV 
positive cells were accompanied by an elevation in ribonucleotide precursors, which 
are synthesized through the pentose phosphate pathway (PPP) (49). For this, we 
examined the incorporation of D-(U-14C)-glucose into total RNA as a measure of 
nucleotide biosynthesis, as described previously (48). Interestingly, as shown in 
Figure 3.2B, despite higher dNTP pools, undifferentiated CIN612 cells exhibited a 
similar level of ribonucleotides to that of HFKs, suggesting that nucleotide 
biosynthesis is not increased by HPV. In contrast, upon differentiation, 
ribonucleotide levels were maintained in CIN612 cells, while they decreased in HFKs 
(Figure 3.2B). While this suggests that HPV may activate the PPP upon 
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differentiation to increase ribonucleotide precursors, we cannot rule out an increased 
ribonucleotide pool also exists in undifferentiated CIN612 cells, but is rapidly 
reduced by the RNR complex to yield elevated dNTP pools.  
 
RRM2 is necessary for HPV replication. We have found that both RRM2 
and dNTP levels are increased in HPV positive cells prior to and during cell 
differentiation. These results suggest that HPV may elevate RRM2 levels to drive 
increased RNR activity to provide dNTPs for viral replication. To determine if RRM2 
is required for viral replication, we utilized RRM2-specific small hairpin RNAs 
(shRNA) and examined the effect of transiently knocking down RRM2 levels on viral 
replication in both undifferentiated and differentiating CIN612 cells. As shown in 
Figure 3.3, transient knockdown of RRM2 in CIN612 cells by two different shRNAs 
resulted in a significant decrease in HPV genome copy number in undifferentiated 
cells. In addition, decreased expression of RRM2 significantly affected the ability of 
viral genomes to amplify upon differentiation. Importantly, expression of the 
differentiation specific marker Involucrin verified that RRM2 knockdown did not 
prevent epithelial differentiation (Figure 3.3). These results suggest that the 
increased levels of RRM2 observed in HPV positive cells play an important role 
throughout the viral life cycle, potentially by providing an adequate supply of dNTPs 
for viral replication.   
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Figure 3.3. RRM2 is necessary for HPV31 replication. CIN612 cells were left 
untreated (UT) or transiently transduced with either a scramble control shRNA 
(shScram) or one of two RRM2 shRNAs (shRRM2) for 72hrs. At this time, DNA and 
protein were either harvested as a T0 (undifferentiated) sample, or cells were exposed 
to high calcium medium to induce differentiation for 72hr. DNA harvested at each time 
point was analyzed by Southern blot analysis using the HPV31 genome as a probe. 
Whole cell lysates harvested at the indicated times points were analyzed by 
immunoblotting to demonstrate cellular differentiation (Involucrin), as well as levels of 
RRM2 in shRNA-transduced cells.  GAPDH was used as a loading control. Fold 
change in episome copy number was determined by performing densitometry of 
episomal bands from three independent experiments using ImageJ software. Shown 
are the fold changes normalized to episome copy number relative to T0 untreated (UT) 
CIN612 cells, which is set at 1. Data are +/- standard error of the means. **p≤ .01. 
IB=Immunoblot. Ca=calcium.  
102 
RRM2 is increased in HPV31 positive cells in an E7-dependent manner. 
A previous study demonstrated that expression of HPV16 E7 alone is sufficient to 
increase RRM2 protein levels (19). To determine if HPV31 E7 is also capable of 
increasing RRM2 levels, we stably expressed HPV31 E6 or E7 alone, as well as E6 
and E7 (E6/E7) in combination in HFKs using a retroviral vector. As shown in Figure 
3.4A, while HPV31 E6 expression resulted in a slight increase in RRM2 protein 
levels compared to HFKs, expression of E7 resulted in a marked increase in RRM2 
levels that was also maintained in cells expressing E6/E7 in combination. In 
contrast, minimal effect was observed on the levels of RRM1. While E7 expression 
alone did result in a slight increase in p53R2 (Figure 3.4A), likely reflecting E7’s 
ability to increase levels of p53 (50), the increase was not maintained in cells 
expressing E6/E7 in combination, correlating with E6’s ability to target p53 for 
degradation (51). Similar results were observed in a previous study (52). To 
determine if the E7-dependent increase in RRM2 protein occurred at the level of 
transcription, we measured RRM2, as well as RRM1 mRNA levels. As shown in 
Figure 3.4B, levels of RRM2 transcripts were significantly increased (~4-fold) in 
HFKs expressing E7 alone, as well as E6/E7 in combination compared to control 
HFKs. Expression of E6 alone resulted in an ~1.5-fold increase in RRM2 transcript 
levels (Figure 3.4B), mirroring the minor increase in RRM2 protein levels observed. 
Although we did not observe a detectable effect of E7 or E6/E7 expression on the 
protein levels of RRM1, both E7 and E6/E7 expression resulted in an ~2-fold 
increase in RRM1 transcript levels compared to HFKs (Figure 3.4B). This 
discrepancy between protein and RNA levels is likely due to the extremely long half-
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life of RRM1 (~15 hours) (7, 14). Overall, these results suggest that RRM2 is 
upregulated primarily by HPV31 E7 and that increased transcription contributes to 
the elevated RRM2 protein levels observed in HPV31 positive cells.  
 
Figure 3.4. HPV31 E7 expression is sufficient to increase RRM2 levels. (A) Whole 
cell lysates harvested from undifferentiated HFKs and HFKs stably expressing HPV31 
E6, E7 or E6/E7 in combination were probed with antibodies to RRM2, RRM1 and 
p53R2, with GAPDH serving as a loading control. (B) RNA was extracted from HFKs 
and HFKs stably expressing HPV31 E6, E7 or E6/E7, and quantitative RT PCR was 
performed to using primers specific to RRM1 and RRM2. Expression levels are shown 
relative to uninfected HFKs and were calculated using GAPDH as the reference gene. 
Fold change was calculated using the 2-ΔΔCT method. Values represent averages from 
four independent experiments across two different HFK backgrounds. Data are +/- 
standard error of the means. *p≤ .05, **p≤ .01. ns=not significant p>.05. 
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E2F1 is required for increased RRM2 expression in HPV31 positive cells. 
Previous studies demonstrated that RRM2 expression is regulated in a manner 
dependent on the E2F1 transcription factor (22). E7 is well known for its ability to 
target Rb and related pocket proteins p130 and p107 for degradation, resulting in 
deregulation of E2F transcription factors and entry into S-phase (53). As shown in 
Figure 3.5A, both HPV31 E7-, as well as E6/E7-expressing HFKs exhibited markedly 
increased levels of E2F1 protein compared to control HFKs, corresponding with the 
increased levels of RRM2 in these cells (Figure 3.4A). E6-expressing cells exhibited 
a modest increase in E2F1 protein levels (Figure 3.5A), mirroring the slight increase 
in RRM2 protein observed (Figure 3.4A). As shown in Figure 3.5B, CIN612 cells also 
exhibited greatly increased E2F1 protein levels compared to HFKs, and the high 
level of E2F1 was maintained upon differentiation in high calcium medium. 
Interestingly, we observed that CIN612 cells, but not uninfected HFKs, consistently 
exhibited a peak in E2F1 that corresponded with an accumulation of RRM2 at early 
times post-differentiation (Figure 3.1B, Figure 3.5B). In contrast, this increase was 
not observed for RRM1 or p53R2.  
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Figure 3.5. E2F1 is required for the increased levels of RRM2 in HPV31 positive 
cells. (A) Whole cell lysates were harvested from HFKs, as well as HFKs stably 
expressing HPV31 E6, E7 or E6/E7 in combination and were probed with an antibody 
to E2F1, with GAPDH serving as a loading control. (B) Whole cell lysates were 
harvested from undifferentiated (T0) HFKs and CIN612 cells, as well as after 48 and 
96hr differentiation in high calcium medium. Immunoblotting was performed using 
antibodies to E2F1, with GAPDH serving as a loading control. (C) Whole cell lysates 
were harvested from HFKs, untreated (UT) CIN612 cells, and CIN612 cells transiently 
transduced with a scramble control shRNA (shScram), or an E2F1 shRNA (shE2F1) 
for 72hrs. Immunoblotting was performed using antibodies to RRM2, RRM1, p53R2 
and E2F1, with GAPDH serving as a loading control. (D) Quantitative RT-PCR was 
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performed to measure RRM2 mRNA levels in untreated (UT) CIN612 cells, as well as 
CIN612 cells transiently transduced with a scramble control shRNA (shScram), or an 
E2F1 shRNA (shE2F1). Expression levels were calculated using GAPDH as the 
reference gene and are shown relative to the untreated (UT) CIN612 cells, which is 
set to 1. Fold change was calculated using the 2-ΔΔCT method. Values represent 
averages from three independent experiments, +/- standard error of the means. *p≤ 
.05, **p≤ .01.  
 
To determine if the increase in RRM2 in HPV31 positive cells was E2F1-
dependent, we examined the effect of E2F1-specific small hairpin RNAs (shRNA) on 
RRM2 transcript and protein levels in CIN612 cells. As shown in Figure 3.5C, we 
observed that E2F1 knockdown resulted in a substantial decrease in RRM2 protein 
levels, with no detectable affect on RRM1 or p53R2. In addition, we found that 
RRM2 transcript levels were significantly decreased upon E2F1 knockdown (Figure 
3.5D), suggesting that E2F1 regulates RRM2 at the transcriptional level in HPV31 
positive cells.  While we did not observe an effect on RRM1 protein levels upon 
E2F1 knockdown, we did observe a slight, but significant decrease in RRM1 mRNA 
levels (Figure 3.5D), which is not surprising as RRM1 is reported to be an E2F1 
target gene (54). Again, the discrepancy observed between RRM1 protein and RNA 
levels upon E2F1 knockdown likely reflects the long protein half-life of RRM1 (7, 14).   
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The increase in RRM2 expression in HPV31 positive cells is dependent 
on the ATR/Chk1 pathway.  Increasing evidence supports a link between 
replication stress, activation of the ATR-Chk1-E2F1 pathway and the accumulation 
of RRM2. Increased RRM2 expression is thought to prevent DNA damage and 
maintain cell viability in response to replication stress by providing dNTPs for 
replication (22, 30, 55). The ATR-Chk1 pathway is constitutively active in HPV 
positive cells (24, 35), suggesting that viral infection induces replication stress. 
Recent studies demonstrated that E7 alone is sufficient to induce Chk1 activation 
(35). These studies raise the possibility that HPV induces RRM2 accumulation 
through Chk1’s ability to increase E2F1 levels. As shown in Figure 3.6A, similar to 
the results of Hong et al (35), we have found that Chk1 is activated (phosphorylated) 
to a higher extent in HPV31 positive CIN612 cells compared to HFKs, and that the 
levels of phosphorylated Chk1 remain elevated upon differentiation. In order to 
determine if HPV31 increases RRM2 levels through Chk1 activation, we used a 
chemical inhibitor of Chk1 activity, UCN-01. Previous studies utilizing this inhibitor 
demonstrated a link between Chk1 activation and RRM2 accumulation in response 
to replication stress upon S-phase entry (22). In addition, recent studies 
demonstrated that UNC-01 inhibition of Chk1 activity blocks productive viral 
replication of HPV31 (35), and we have confirmed those results here (Figure 3.6B).  
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Figure 3.6. HPV31 increases RRM2 levels in a Chk1-dependent manner. (A) 
Whole cell lysates were harvested from undifferentiated (T0) HFKs and CIN612 cells, 
as well as after 48 and 96hr differentiation in high calcium medium. Immunoblotting 
was performed using antibodies to phosphorylated Chk1 (Ser345) and total Chk1, with 
GAPDH serving as a loading control. (B) DNA and protein were harvested from 
CIN612 cells at T0 (undifferentiated), as well as after 24, 48, and 72hr differentiation 
in high calcium media containing either DMSO or 300nM of the Chk1 inhibitor UCN-
01. Southern blot analysis was performed using the HPV31 genome as a probe. 
Immunoblotting was performed using antibodies to Involucrin, with GAPDH serving as 
a control.  (C) Whole cell lysates were harvested from undifferentiated CIN612 cells 
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that were left untreated (UT) or treated with DMSO or 300nM of the Chk1 inhibitor 
UCN-01 for 24 hours. Western blot analysis was performed using antibodies to RRM2, 
E2F1, RRM1 and p53R2, with GAPDH serving as a loading control. Protein levels 
were quantified by densitometry using ImageJ software and were normalized to the 
GAPDH loading control. Shown are the fold differences relative to the UT CIN612 
cells, which is set to 1. (D) Whole cell lysates harvested from undifferentiated CIN612 
cells (T0), as well as CIN612 cells differentiated for 24, 48, and 72hr in high calcium 
medium containing either DMSO or 300nM UCN-01 were examined by 
immunoblotting using antibodies to RRM2, E2F1, RRM1, and p53R2, with GAPDH 
serving as a control. Protein levels were quantified by densitometry using ImageJ 
software and were normalized to the GAPDH loading control. Shown are the fold 
differences relative to the T0 CIN612 sample, which is set to 1. (E) RNA harvested 
from undifferentiated (T0) CIN612 cells, as well as CIN612 cells harvested at 24hr 
post-differentiation in high calcium in the presence of DMSO or 300nM UNC-01 was 
analyzed by quantitative RT PCR using primers specific to RRM2. Expression levels 
were calculated using GAPDH as the reference gene and are shown relative to the 
UT CIN612 cells, which is set to 1. Fold change was calculated using the 2-ΔΔCT 
method. Values represent averages from three independent experiments, +/- standard 
error of the means. (F) Whole cell lysates were harvested from undifferentiated (T0) 
CIN612 cells and CIN612 cells differentiated for 24, 48, and 72hr in high calcium 
medium containing either DMSO or 10uM of the ATR inhibitor VE-821. Immunoblotting 
was performed using antibodies to RRM2 and E2F1, with GAPDH serving as a control. 
Ca=calcium. 
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We first examined the effect of Chk1 inhibition on RRM2 and E2F1 protein 
levels in undifferentiated CIN612 cells. As shown in Figure 3.6C, we found that 
inhibition of Chk1 activity prior to differentiation resulted in decrease in both RRM2 
(~50%) and E2F1 (~37%) protein levels, while having no effect on RRM1 or p53R2. 
We next examined whether Chk1 activity is required for the accumulation of RRM2 
and E2F1 at early times post-differentiation in HPV31 positive cells. For this, we 
exposed CIN612 cells to high calcium medium in the presence or absence of UNC-
01 for 24, 48 and 72hr (Figure 3.6D). Again, while there was no detectable effect of 
Chk1 inhibition on protein levels of RRM1 or p53R2, the accumulation of RRM2 was 
blocked at 24hr post-differentiation, as was E2F1. Concomitant with the reduction in 
E2F1 protein levels upon Chk1 inhibition, RRM2 message levels also decreased by 
~2-fold (Figure 3.6E), suggesting that Chk1 increases RRM2 levels in an E2F1-
dependent manner.  
To further confirm the importance of the ATR-Chk1 signaling pathway in the 
upregulation of RRM2, we examined the effect of a chemical inhibitor of ATR (VE-
821) on the accumulation of RRM2, as well as E2F1 upon differentiation. As shown 
in Figure 3.6F, similar to the results observed upon Chk1 inhibition, we found that 
the accumulation of both E2F1 and RRM2 was attenuated upon ATR inhibition. 
Overall, these results suggest that activation of the ATR/Chk1 pathway in HPV 
positive cells is required to provide an environment conducive to viral replication by 
activating E2F1-dependent RRM2 accumulation.  
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DISCUSSION 
RRM2 is considered the rate-limiting component of the RNR enzyme and is 
required for de novo synthesis of dNTPs, along with RRM1 (5). Increased RRM2 
levels are associated with greater RNR activity and this is reflected in our finding that 
along with higher RRM2 levels, HPV positive cells also have higher levels of dNTPs 
compared to uninfected HFKs. Importantly, high RRM2 and dNTP levels are 
maintained during the productive phase of the viral life cycle and are likely a 
necessary resource for the rapid amplification of viral genomes in a differentiating 
environment. In support of this, we have found that that loss of RRM2 expression 
leads to a lower viral copy number in undifferentiated cells and a block in productive 
viral replication upon differentiation. In contrast, while the levels of the alternate R2 
subunit p53R2 were similar between undifferentiated HPV positive and HPV 
negative cells, upon differentiation p53R2 levels decreased in HPV31 positive cells. 
Though we cannot rule out a role for p53R2 in viral replication, the finding that high 
levels of RRM2 are maintained, while levels of p53R2 decrease upon differentiation, 
coupled with the block in productive replication observed upon RRM2 knockdown, 
argues against this.  
The finding that transient knockdown of RRM2 expression leads to a 
decrease in HPV31 copy number in undifferentiated cells is not entirely surprising 
given that RRM2 loss is associated decreased dNTP pools (16, 17). Under 
conditions of limited dNTPs, synthesis of viral DNA is likely to be outcompeted by 
the host for access to cellular substrates required for replication.  Previous studies 
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with Epstein Barr virus yielded similar results in that inhibition of RRM2 function 
upon treatment with hydroxyurea, as well as use of RRM2 siRNAs both led to a loss 
of viral episomes from infected cells (56, 57). Under normal conditions in 
undifferentiated cells, the small size of the HPV genome, coupled with a low viral 
copy number, likely does not provide much of a drain on cellular resources, allowing 
the virus to replicate once per cell cycle along with cellular DNA. Upon 
differentiation, however, productive replication is thought to occur post-cellular DNA 
synthesis as cells transition from S- to G2-phase (4), resulting in amplification from 
50-100 copies per cell to 1000s of copies per cell. It is possible that the preceding 
synthesis of cellular DNA upon re-entry into the cell cycle may limit cellular 
substrates, requiring HPV to increase RRM2 levels to provide dNTPs necessary to 
facilitate amplification of viral genomes.  
It is currently unclear whether the elevation in dNTP pools observed in HPV 
positive cells is also accompanied by increased ribonucleotide precursors 
synthesized through the pentose phosphate pathway, which branches from 
glycolysis at the first committed step (49). While we have found that undifferentiated 
HFK and HPV31 positive cells exhibit similar levels of ribonucleotides, this may 
simply reflect the increased reduction of ribonucleotides to deoxyribonucleotides as 
a result of increased RRM2 levels and RNR activity. In contrast, ribonucleotide 
levels remain elevated in HPV31 positive cells relative to HFKs upon differentiation, 
corresponding with maintenance of dNTP pools. Therefore, it is possible that HPV 
alters nucleotide metabolism at multiple levels to increase dNTP pools. 
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Understanding the effect of HPV on the pentose phosphate pathway throughout the 
viral life cycle will be an important area of future research. 
Our studies indicate that HPV increases levels of RRM2 through activation of 
the ATR-Chk1-E2F1 DNA damage response (DDR) pathway, with no detectable 
effect on RRM1 or p53R2. These results mirror recent findings by Ricardo-Lax et al, 
in which hepatitis B virus was shown to increase dNTP pools in quiescent cells 
through increased RRM2 levels in a Chk1-E2F1-dependent manner (58). Activation 
of the ATR-Chk1 pathway is central to the cell’s response to replication stress, and 
several studies have shown that this pathway is constitutively active in HPV positive 
cells (24, 35). Importantly, recent studies demonstrated that Chk1 activity is required 
for productive replication of HPV31 (35), a finding we have confirmed in this study. 
The constitutive activation of ATR and Chk1 indicates that replication stress may be 
a constant occurrence in HPV-infected cells and present throughout the viral life 
cycle. We have found that ATR and Chk1 activity is required for the increased levels 
of E2F1 and RRM2 in undifferentiated HPV31 positive cells, as well as the 
accumulation of E2F1 and RRM2 at early times post-differentiation. This observation 
is reminiscent of studies by Buisson et al who demonstrated that S-phase entry 
induces replication stress due to a large demand on dNTPs at a time when RRM2 
levels are still low (30). This in turn activates the ATR-Chk1 pathway, leading to 
increased levels of RRM2 in an E2F1-dependent manner to provide dNTPs to 
maintain genomic stability and cell viability (30). Our finding that activation of the 
ATR-Chk1 pathway is required for elevated RRM2 levels in HPV31 positive cells 
suggests that HPV-induced cell cycle re-entry upon differentiation elicits an E2F1 
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transcriptional response through activation of ATR and Chk1 that culminates in 
increased RRM2 levels, likely providing dNTPs required for productive viral 
replication. Importantly, this study indicates that ATR/Chk1 activation is required to 
maintain a replication-competent environment in differentiating HPV positive cells.  
The mechanism by which Chk1 leads to accumulation of E2F1, and in turn 
RRM2, in HPV positive cells is currently unclear, though several possibilities exist. 
Chk1 has been shown to phosphorylate E2F6, a negative regulator of E2F-
responsive genes, upon replication stress, resulting in its removal from E2F-
responsive promoters, allowing E2F1 to bind (20). Other studies have shown that 
E2F1 is phosphorylated in response to activation of the ATR-Chk1 pathway, leading 
to increased protein stability and transactivation potential, resulting in increased 
RRM2 levels (22, 30, 59). Future studies will focus on understanding the link 
between ATR-Chk1 signaling and increased E2F1 levels in HPV positive cells. 
Increasing evidence supports the idea that oncogenes induce replication 
stress, especially those that promote uncontrolled S-phase entry (60-63). In regards 
to HPV, several studies have demonstrated that expression of HPV16 E7, and to a 
lesser extent E6, induce ATR/Chk1 activation (34, 35). In addition, studies by Bester 
et al demonstrated that expression of HPV16 E6/E7 results in perturbed replication, 
leading to replication stress and DNA damage attributed to E7’s ability to target Rb 
for degradation and promote cell cycle entry through deregulation of E2F 
transcription factors (33). Interestingly, a previous study suggested that the HPV16 
E7-dependent increase in RRM2 transcription occurs in an E2F-dependent manner 
and requires an intact Rb binding domain (19). In our study, we have found that 
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HPV31 E7 alone is also sufficient to increase levels of RRM2, suggesting that this 
may be a conserved feature of HR HPVs. In addition, expression of HPV31 E7 alone 
increases the levels of E2F1. Taken together, these results suggest that in HPV-
infected cells, E7-induced S-phase entry results in replication stress that leads to 
increased levels of RRM2 in an ATR/Chk1-E2F1-dependent manner, in turn 
providing an environment conducive to productive viral replication.  
While uncoordinated proliferation can lead to insufficient dNTPs that cause 
replication stress and promote genomic instability, elevated dNTP pools can also be 
highly detrimental, leading to DNA breaks, mutagenesis and even cell death (64). A 
recent survey identified RRM2 as being among the top 10% of overexpressed genes 
in 73 of 168 cancer analyses that involved multiple types of cancer, including 
cervical cancer (64).  High levels of genomic instability are detected in HPV-
associated pre-cancerous lesions (65). Our observation that high-risk HPV positive 
episomal lines exhibit markedly increased levels of RRM2 suggests that genomic 
instability could potentially arise in pre-cancerous lesions, at least in part, through 
increased RNR activity and elevated dNTPs. In addition to de novo dNTP synthesis, 
RRM2 overexpression is also associated with increased cellular invasiveness, 
angiogenesis, and proliferation in human cancer cells. Recent studies demonstrated 
that RRM2 overexpression in cervical cancer cells leads to production of reactive 
oxygen species (ROS) that enhances angiogenesis through HIF-1 alpha and VEGF 
production (19). The expression of angiogenic factors and increased microvessel 
density occur very early in the development of HPV-induced pre-cancerous lesions 
and cervical cancers (66, 67). Understanding if RRM2 overexpression is linked to 
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increased mutagenesis, as well as angiogenesis in HPV-induced pre-cancerous 
lesions will provide important insight into the contribution of RRM2 in promoting 
carcinogenesis of HPV-associated lesions.  
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CHAPTER 4: SUMMARY, CONCLUSIONS, AND FUTURE DIRECTIONS  
GENERAL SUMMARY  
In this dissertation I investigated HPV and host keratinocyte interaction, 
specifically focusing on how HPV engages the host DNA damage response in order 
to replicate the viral genome. In doing this I investigated viral interaction with two of 
the major cellular pathways involved in the sensing and repair of DNA damage: the 
ATM and ATR DNA damage repair pathways. Previous to my research activation of 
both of these pathways had been shown to be necessary for productive viral 
replication, but specific contributions of individual proteins and mechanism of activity 
remained to be investigated (1-3). My research identified specific proteins involved in 
these pathways that are necessary for productive viral replication, and proposed 
mechanisms through which they could be contributing to viral replication. I 
investigated the role of Nbs1 and MRN complex activity in HPV productive 
replication and how the ATR-Chk1 DNA damage response is involved in maintaining 
an environment conducive for productive viral replication upon host cell 
differentiation. Better understanding how HPV engages host DNA damage pathways 
in order to replicate its genome is important for the development of new and curative 
antiviral therapies.  
In the first chapter of this dissertation I outlined the ATM and ATR DNA 
damage response pathways. In addition to explaining how they are used to respond 
to cellular DNA damage I detailed how HPV engages these pathways in order to 
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replicate its genome. In chapter two I expanded upon what was previously known 
about the involvement of the ATM DDR in HPV productive replication. I discovered 
that Nbs1 is necessary for productive HPV viral replication upon host cell 
differentiation. Specifically, I found that HPV requires Nbs1 and MRN complex 
activity to recruit homologous repair (HR) factors to viral replication centers, which 
may be why Nbs1 is required for HPV productive replication. Chapter three deals 
with the ATR DNA damage response and deoxyribonucleotide triphosphate (dNTP) 
supply. Previous research has shown that RRM2, an important rate limiting protein 
involved in dNTP synthesis is upregulated in HPV positive cells (4). More recently 
Hong et. al. discovered that ATR and Chk1 activity are necessary for HPV 
productive viral replication, however the mechanism by which it is required was not 
investigated (3). In my research we observed elevated dNTP pools in HPV positive 
cells both pre and post differentiation and a ATR-Chk1 dependent elevation of 
RRM2 levels in these same cells that was necessary for productive viral replication. 
These results tied together the previously observed elevated RRM2 levels and the 
requirement for ATR-Chk1 activity to suggest that the ATR pathway is important for 
providing dNTPs required for productive replication. 
Together my research projects discussed in this dissertation further our 
knowledge of HPV manipulation of host cell factors in order replicate its genome. In 
this dissertation I have described important pathways utilized by the virus in order to 
upregulate and recruit factors necessary for viral genome replication. In this final 
chapter I will integrate these two pathways exploited by HPV in the greater context 
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of HPV infection and the exciting future research directions raised by these insights 
into virus/host interaction. 
HOMOLOGOUS REPAIR DEPENDENT HPV REPLICATION 
HPV is thought to exhibit three major types of viral replication; establishment 
replication upon initial infection, maintenance replication while the host keratinocyte 
remains in the basal layer, and productive replication upon differentiation of the host 
keratinocyte. Since Moody and Lamins first discovered the involvement of the ATM 
DNA damage pathway in the HPV lifecycle, there has been mounting evidence that 
ATM and other homologous repair proteins play a role in productive viral replication 
(1, 2). In my research I set out to elucidate roles for specific proteins in this pathway. 
The MRN complex composed of Mre11, Rad50, and Nbs1, is known to be 
upregulated in HPV positive cells, and to localize to sites of HPV genome synthesis. 
The traditional role of the MRN complex is the recruitment of ATM to the site of DNA 
double strand breaks. Nbs1 specifically is a well-known downstream effector of ATM 
and is activated by phosphorylation in an ATM dependent manner. Considering this 
previous data, we hypothesized that Nbs1 was playing an important role in the HPV 
lifecycle and viral replication. 
The first step in this process was to determine the mechanisms by which 
Nbs1 and the other MRN components were upregulated in HPV positive cells. Using 
an established system to express HPV31 E7 in HFKs we determined that E7 
expression was sufficient to upregulate levels of all three MRN component proteins. 
Interestingly, while levels of all three proteins were elevated only Mre11 transcription 
was significantly increased. This is consistent with Mre11’s role as the binding 
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partner of both Nbs1 and Rad50 and its ability to stabilize both proteins (5, 6). To 
determine the importance of Nbs1 upregulation and recruitment to HPV DNA 
centers, I used a validated shRNA to knock down Nbs1 protein levels and observe 
the effect on HPV replication.  
The hypothesis was, since ATM activity was necessary for HPV productive 
replication and Nbs1 is known to be an important activator of ATM, depletion of 
Nbs1 would lead to a defect in productive viral replication due to a lack of ATM 
activation. Interestingly, although productive replication was affected in a manner 
similar to that seen in ATM deficient cells in previous studies, there was no 
consistent or significant effect on ATM or Chk2 activation as measured by 
phosphorylation. This is inconsistent with a model requiring Nbs1 mediated ATM 
activation to promote productive viral replication. Instead this data suggested both, 
that an alternative ATM activating pathway must be at work and that Nbs1 must be 
affecting productive replication outside of ATM activation. Downstream of ATM 
activation, Nbs1 is known to play a role in both cell cycle control at the intra-S-phase 
checkpoint and DNA damage induced apoptosis however neither of these pathways 
were affected by Nbs1 knockdown.  
In addition to these functions downstream of ATM activation, previously 
published data suggested that protein-protein interaction motifs on Nbs1 were 
important for recruitment of the MRN complex (7, 8) and other HR proteins including 
Rad51 (9) to nuclear foci. Furthermore, activity of the MRN complex and other 
proteins recruited by Nbs1 is known to be important for the processing of broken 
ends of DNA and initiation of HR (10). To see if Nbs1 depletion was affecting these 
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pathways I knocked down Nbs1 in HPV positive cells and conducted a cytoplasmic-
nuclear fractionation. This was compared to fractionations performed on untreated 
HPV positive cells and normal HFKs. The fractionation showed an enrichment of 
nuclear MRN in the infected cell compared to the HFK. However, in the absence of 
Nbs1, levels of nuclear Mre11 and Rad50 decreased and instead these proteins 
were found localized to the cytoplasm. In addition, through the use of HPV genome 
specific FISH and immunofluorescence we found that Mre11, Rad50, and Rad51 
were recruited to HPV DNA foci in the nucleus both prior to and post differentiation 
with significant increases in Mre11, Rad50 and Rad51 positive foci observed upon 
differentiation. Interestingly while Nbs1 depletion abrogated this recruitment of 
Mre11 and Rad50 at all time points, Rad51 recruitment was only negatively affected 
upon differentiation. Furthermore, I was able to show that not only was Mre11 
recruited to viral replication centers by Nbs1, but using the Mre11 nuclease inhibitor 
mirin, I was able to show that Mre11 nuclease activity was also necessary for 
productive viral replication. Nbs1 is thought to recruit Mre11 to broken DNA ends 
where Mre11 processes these broken ends of DNA by resection. These finding 
support the current hypothesis that, upon differentiation HPV switches to a HR 
dependent method for viral DNA synthesis, since Mre11 nuclease activity at the sites 
of replication may be necessary for the recruitment of further HR factors such as 
Rad51 (11). In fact, this is further supported by even more recently published 
research from the Moody lab showing that the HR factors Rad51 and Brca1 are 
necessary for productive viral replication upon differentiation. These results, in 
combination with other previously published studies, suggest a model in which HPV 
128 
engages ATM, which signals through Nbs1. This Nbs1 activity may be important for 
recruitment of HR factors to sites of viral DNA synthesis. Otherwise, the lack of 
amplification occurring in the absence of Nbs1 may be leading to the lack of further 
HR factors being recruited. Then, upon differentiation this signaling is magnified and 
the assembled factors facilitate massive viral DNA synthesis through a HR 
dependent mechanism. 
The model of a switch to an ATM and HR dependent mechanism for 
productive viral genome replication upon differentiation has been growing in strength 
since Moody and Laimins first found that ATM and Chk2 activity were necessary for 
productive viral DNA replication but not genome maintenance (1). The work detailed 
in my second chapter further supports this hypothesis by identifying two further ATM 
dependent HR proteins required for productive viral replication that have little effect 
on viral genome maintenance. Further research on this topic has been conducted in 
our laboratory by Chappell et al (12), showing that Brca1 and Rad51 are also 
necessary for productive viral replication. This is interesting since Brca1 is known to 
work in concert with Mre11 in the resection of double strand breaks and then to aid 
in the recruitment and stabilization of Rad51 at sites of DNA damage. Together with 
my research this suggests a model in which Nbs1 is bringing Mre11 and Rad51 to 
sites of viral DNA synthesis upon differentiation and that the interaction of these 
proteins are necessary for productive replication (Figure 4.1). Conversely it is 
possible that Rad51 is recruited in an Nbs1 independent manner and Mre11 activity 
at the site of DNA synthesis is responsible for the accumulation of Rad51. This could 
be potentially explored by repeating the mirin treatment of HPV positive cells and 
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observing the localization of Rad51 via FISH/IF as was done in the case of Nbs1 
knock down. This hypothesis could be further investigated by expressing either Nbs1 
deficient in Mre11 binding or vice versa, to determine if recruitment of Mre11 is an 
essential activity of Nbs1 necessary for productive viral replication. Finally, it would 
be interesting to determine if HR itself was essential for HPV replication. Chemical 
inhibition of DNA-PK auto phosphorylation or overexpression of DNA-PK with 
mutations in the auto phosphorylation cluster site has been shown to block 
progression of HR by preventing DNA-PK release from broken DNA ends, 
preventing end processing and the recruitment of HR factors (13, 14) (reviewed in 
(15)). It may be interesting to use these systems in HPV positive cells to determine if 
recruitment of HR factors to sites of HPV replication or productive genome 
replication was affected.  
MODULATION  OF ATR  DNA DAMAGE PATHWAY TO  PROVIDE 
REPLICATION FACTORS 
As detailed in the introduction the HPV lifecycle is tightly regulated and linked 
to host cell differentiation. In order to avoid detection from the immune system HPV 
infection in basal keratinocytes exists in a maintenance state replicating its genome 
once per cell cycle along with the host genome. It is not until the host cell begins 
differentiate and move upward away from the basal layer and immune surveillance, 
that productive viral replication takes place (16). However, since differentiating cells 
have exited the cell cycle, this means that HPV must somehow manipulate the host 
cell environment in order to provide factors necessary for viral genome amplification 
to thousands of copies per cell. As previously outlined the virus accomplishes this 
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through the expression of its early genes, especially E6 and E7 which target p53 and 
Rb respectively. In addition, a growing body of evidence points to activation of the 
cellular DNA damage pathways in order for HPV to alter cell cycle regulation. Work 
covered in the second chapter of this dissertation focused on the ATM DNA damage 
pathway, a well-studied way in which HPV alters cell cycle regulation and provides a 
replication competent atmosphere. In addition, recent evidence suggest that HPV 
may also be targeting the ATR mediated DNA damage pathway in order to allow for 
productive replication upon host cell differentiation. The third chapter of my 
dissertation describes one mechanism by which HPV infection may be exploiting the 
ATR mediated DNA damage pathway in order to provide factors necessary for HPV 
viral DNA synthesis. 
Recently published research has shown that ATR is constitutively activated in 
HPV positive cells and that this activation is required for successful productive HPV 
replication upon differentiation, however no mechanism was proposed (3). Also, 
separate research has shown that the small subunit of RNR, RRM2 is upregulated in 
HPV positive cervical cancer cells in an E7 dependent manner (4). I therefore set out 
to examine the importance of both this ATR activation and RRM2 upregulation in the 
context of HPV infection, especially as it affected HPV viral genome replication. 
Previous work had only measured RRM2 levels in cervical cancer cells where the 
viral genome has integrated, RRM2 levels had not been examined in the context of 
the complete differentiation dependent lifecycle. Since the largest amount of HPV 
viral genome synthesis occurs during productive replication upon differentiation I 
verified that RRM2 was upregulated upon differentiation. Upregulation of RRM2 
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protein levels and gene expression were not only present upon differentiation in HPV 
positive cells, but were increased compared to HFKs. Importantly since RRM2 is 
thought to be a major rate limiting component in the synthesis of dNTPs, we verified 
that levels of all dNTPs were indeed upregulated in HPV positive cells both prior to 
and upon differentiation. Next, using an RRM2 specific shRNA I determined that 
RRM2 is necessary for HPV productive replication. Interestingly I also observed this 
productive replication deficiency when I treated differentiating HPV positive cells with 
Chk1 inhibitors, recapitulating the results seen by Hong et al. (3). In addition, we saw 
a significant decrease in both E2F1 and RRM2 protein levels in these cells. The 
decrease in E2F1 was important because activation of ATR has previously been 
shown to upregulate RRM2 levels in a Chk1-E2F1 dependent manner. These 
results, combined with the observation that ATR inhibition and E2F1 knock down in 
HPV positive cells also decreased RRM2 expression, led me to a model in which 
HPV is engaging the ATR DNA damage response, either directly or through the 
creation of replication stress in order to upregulate RRM2 expression to provide 
dNTPs for viral DNA synthesis in differentiating cells (Fig 4.1). This is important 
because, while ATR activation in HPV positive cells had been observed for some 
time, this model suggests a reason why this activation may be helpful to the virus. 
Also, the model proposes a method by which the virus may be manipulating the host 
cell to provide one of the most important factors for viral DNA synthesis, dNTPs. 
Elevated RRM2 levels and dNTP pools being necessary for the replication of an 
oncovirus is an interesting result. Recent research has shown that elevated RRM2 
levels correlate to a poor cancer prognosis (17-20). Also, lower levels of RRM2 and 
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a subsequent lack of dNTPs is thought to lead to oncogene-induced senescence in 
cancer cells (21-23). 
While this work and the resulting model is an important step forward in 
understanding the role of ATR and Chk1 signaling through E2F1 to RRM2 in the 
HPV lifecycle and genome replication some questions remain unanswered. More 
must be done in order to fully explain the link between ATR-Chk1 signaling, RRM2 
upregulation, dNTP supply and productive viral replication. First, while I have shown 
that both RRM2 and dNTPs are upregulated in HPV positive cells, I have not shown 
that the increase in dNTPs is a direct result of RRM2 upregulation. I have shown that 
there is an increase in ribonucleotide pools in HPV positive cells, however it would 
be useful to determine if RRM2 knockdown in these cells resulted in lower dNTP 
pools as well as a defect in viral genome replication. This could strengthen the 
hypothesis that HPV is upregulating RRM2 production in order to supply dNTPs for 
viral genome synthesis. Also, more could be done to strengthen the argument that 
the increased RRM2 expression is necessary to provide dNTPs for viral genome 
replication and that this is indeed regulated by a Chk1-E2F1 interaction. Rescuing 
productive viral reproduction by suppling deoxy ribonucleosides would be an obvious 
first step. Also, a rescue of replication in the presence of ATM or Chk1 inhibition 
using an RRM2 or E2F1 expression vector would strengthen the argument that 
E2F1 regulation by ATM-CHk1 signaling is important. One final point not addressed 
in this work that would be interesting to investigate, would be the contribution of the 
upstream pathways involved in nucleoside production including the pentose 
phosphate pathway. While we have determined that the steady state pools of 
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ribonucleotides are similar in undifferentiated HFK and HPV positive cells and only 
slightly elevated in HPV positive cells upon differentiation, we have not determined if 
higher levels of ribonucleosides are being produced, but are just as quickly being 
reduced by the increased RRM2 activity. 
DISSERTATION IMPACT 
In order to successfully infect its host, reproduce and pass on its genetic 
material every virus must accomplish two things: avoid or repress immune detection 
and commandeer necessary cellular machinery in order to express its proteins and 
replicate its genome. Through its relatively small size and coding capacity and its 
cell cycle dependent regulation of gene expression and genome replication, HPV 
does a fairly good job at accomplishing immune evasion. However, these same 
factors make viral genome replication even more complicated. One of the most 
challenging problems faced by HPV is how to massively replicate its genome in a 
cell that has exited the cell cycle. As outlined in this dissertation HPV is known to 
interact with many host cell signaling pathways in order to push the host cell back 
into the cell cycle and to freeze the cell in what is thought to be a G2/M arrested 
state (Fig. 4.1). The question addressed in my dissertation is how in this state, does 
HPV regulate and recruit host factors necessary for productive viral replication. 
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Figure 4.1 HPV E7 engages both the ATM and ATR DDR pathways in order to 
recruit host factors and promote viral genome amplification.  
 
My work begins to unite the current ATM and HR dependent productive viral 
replication model with a hypothesis that HPV also exploits ATR signaling, to further 
activate E2F factors to activate transcription of factors important for viral genome 
replication (Fig 4.1). Currently, it is believed that upon host cell differentiation, viral 
genome replication switches from the bidirectional theta replication seen in 
maintenance phase infection to a different form of DNA synthesis. This separate 
form of viral genome replication has been shown to require many components of the 
ATM DDR and HR (Fig 4.2) (1, 12, 24, 25) (reviewed in (11)).  
135 
 
Figure 4.2 DNA HR factors are recruited to HPV replication centers in order to 
facilitate HR dependent viral genome amplification. Several HR factors have 
been shown to be recruited to sites of HPV viral genome amplification. These factors 
have been shown to be necessary for productive viral genome amplification upon 
host cell differentiation. I propose a model in which these factors are recruited to 
breakage sites in HPV episomes. Neighboring episomes are then used as a 
template for synthesis of a new viral episome. In this way, tightly packed HPV 
episomes serve as templates to prime the synthesis of new episomes in a manner 
similar to sister chromatids serving as template DNA for HR of double strand breaks 
in the host genome. This process, happening simultaneously from multiple sites on 
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the many tightly packed HPV episomes present in replication foci, could result in the 
massive and rapid amplification of HPV episomes observed during host cell 
differentiation. 
The discovery of Nbs1 involvement in this productive viral replication is 
important because, not only is it known to interact with ATM in the DDR, but Nbs1 is 
also recruited to sites of DNA damage and is known, together with the other 
components of the MRN, to recruit important repair factors to these sites. This role 
for Nbs1 and the MRN in the DDR is consistent with my observations of the 
necessity for Nbs1 and Mre11 activity for HPV productive replication. In the context 
of HPV replication, I found that Nbs1 and the activity of the MRN complex are 
required, but somehow outside of ATM activation. My research suggests that Nbs1 
is important for productive viral replication due at least in part to its ability to recruit 
other HR factors including Mre11. Overall, productive replication of HPV genomes is 
a poorly understood process, hopefully further understanding of the recruitment of 
HR factors to sites of viral genome replication will lead to methods by which we can 
block this replication and the spread of infection. 
While we are still researching the HR factors recruited to sites of viral genome 
replication through ATM and Nbs1 and how these HR factors impact viral DNA 
synthesis, it is still important to understand how the necessary dNTP pools for this 
synthesis are maintained in differentiating cells. Typically, the post mitotic 
differentiating cell would not provide necessary factors for large scale DNA 
synthesis. While HPV infection does push the cell back into the cell cycle and is 
thought to hold the cell in a G2/M arrested state, this is still not an ideal state for 
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DNA synthesis. However, I have shown that dNTP pools are maintained at a high 
level in differentiating HPV positive keratinocytes. Furthermore, I have described a 
pathway by which HPV may be engaging the ATR DDR to activate RRM2 
expression in order to ensure the availability of these dNTP pools (Fig 4.1). These 
discoveries are important because they give weight to new evidence that ATR is 
required for productive HPV replication. This data suggests that drugs targeting 
RRM2 may be useful antivirals against HPV infection and replication.  
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